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Abstract 
This study investigated the role that registered nurses play in the conduct of clinical trials in 
Australia. Rapid expansion in clinical research in the last decade has led to a significant 
increase in the number of clinical trials conducted globally. This has led to an increase in the 
number of health professionals engaged in different roles within clinical trials research and 
practice, notably registered nurses. With their knowledge of disease and healthcare training 
background, an increasing number of registered nurses have transitioned from the clinical 
setting to clinical research, filling positions in trial coordination and management. The 
current literature describing the roles and responsibilities of nurses working in clinical trials 
is mainly anecdotal in nature with very little published original research.   
 
The aim of this study was to explore the role of registered nurses in clinical trials from the 
perspective of clinical trial nurses and medical research principal investigators. Data were 
collected from ten registered nurses and ten medical practitioners from a range of clinical 
backgrounds using individual face to face interviews. Interview transcripts were analysed 
using Gadamer’s hermeneutic methodology to identify and create themes that describe the 
reality of the role that registered nurses play in the conduct of clinical trials in Australia. 
 
One overarching theme supported by two subthemes were identified that helped explain the 
role that registered nurses play in clinical trials. The overarching theme was ‘Being a Nurse’, 
supported by subthemes: ‘Functioning within a professional nursing framework’ and 
‘Therapeutic knowledge and clinical skills’. The findings revealed that registered nurses 
working in clinical trials research enacted their role from within their professional nursing 
framework applying their nursing experience and clinical knowledge in clinical trials 
research conduct and management. As well as this, key challenges in regards to their role in 
x 
 
the informed consent process, collegial support and establishing their identity within the 
broader nursing community were identified. 
 
In conclusion, this study has provided an initial observation into the world of nurses working 
in clinical trials research. The results also highlight what may be necessary to guide and 
develop nurses to progress further within this role. There is a need to explore more around the 
role of clinical trial nurses and to define the scope of practice for nurses in this role. 
Moreover further work needs to be done in identifying competencies and standards for 
registered nurses using their specialist nursing skills within a research role.  
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Chapter 1: Introduction to Research Study 
1.0 Introduction 
Clinical trials research has seen rapid growth in both the number of studies and breadth of 
study areas. The expansion of international clinical trials research has led to increased 
infrastructure support, particularly staffing, and as part of this, specific roles such as the 
clinical trial nurse (CTN) have evolved. However, the role of nurses working in clinical trials 
research in Australia has not been formally defined nor explored in depth. This thesis 
examines the role of CTNs in clinical trials research in Australia utilising hermeneutic 
philosophical underpinnings. 
 
In this chapter, a broad overview of the contribution of clinical trials research to healthcare is 
briefly discussed. The researcher’s professional background leading to this research topic, the 
primary research question and an overview of the process that underpins this research is also 
presented. The chapter concludes with a brief outline of each of the other chapters, presented 
to provide an overview of the thesis. 
1.1 Background to the Study 
Clinical research is a key component of healthcare systems, contributing to the development 
of new therapeutic agents, new interventions, improving current clinical practices and 
sometimes revealing the deficiencies in these areas (Friedman, Furberg and DeMets, 2010). 
This was highlighted in final report of the Australian National Health and Hospital Reform 
Commission (2009), which stated that ongoing research contributed to the progress of health 
care, whereby research needs to be recognised, valued and integrated within the health 
system. Clinical research is fundamental and an important component of the health care 
system in Australia driving the development and improvement of more effective, evidence- 
based medicine. This is echoed in the final report of the National Health and Hospital Reform 
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Commission (2009, p32) stating, ‘To promote research and uptake of research findings in 
clinical practice, we recommend that clinical and health services research be given higher 
priority’.  
 
Clinical research is conducted using various methods. However, clinical trials are now at the 
forefront of clinical research methods used to evaluate therapeutic interventions (Friedman et 
al., 2010; Piantadosi 2005). Clinical trials research aims to test interventions and therapies to 
identify the best possible way to diagnose and treat disease in people, and consequently has 
become the preferred tool and methodological approach that underpins evidence-based 
research and practice (Friedman et al., 2010). Furthermore, the conduct of clinical trials                 
impact in delivering actual outcomes to the population. The National Health and Medical 
Research Council (NHMRC) of Australia National Statement on Ethical Conduct in Human 
Research (2007) defines clinical trials as:  
„a form of human research designed to find out the effects of an 
intervention, including a treatment or diagnostic procedure which can 
involve testing a drug, a surgical procedure, other therapeutic 
procedures and devices, a preventive procedure, or a diagnostic device 
or procedure.’ p (32) 
The National Health and Medical research Council (NHMRC) is Australia’s foremost expert 
body promoting the development and maintenance of public and individual health standards 
together under a single national organisation for the functions of research funding and 
development of advice (http://www.nhmrc.gov.au/about/organisation-overview/nhmrcs-role). 
NHMRC allocates its funding via grants and fellowships, with a majority of these being 
allocated to medical practitioners who conduct clinical research as principal investigators. 
Principal investigators have the responsibility to ensure that all tasks and requirements of 
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clinical trials research are met including ensuring appropriate staff skills and adequate 
personnel to conduct clinical trials (http://www.ich.org). Therefore medical practitioners play 
an important role in the employment and management of clinical trials research personnel. 
Clinical trials research in Australia is conducted according to regulations set by the 
Therapeutic Goods Administration (TGA) and standards set by the NHMRC. The TGA is a 
division of the Australian Government Department of Health and Ageing, responsible for 
regulating and evaluating therapeutic goods including medicines, medical devices, blood and 
blood products (http://www.tga.gov.au).  
Investment in clinical trials research in Australia has enormous potential for economic and 
health benefits for Australians.  These include faster access to newly developed therapeutic or 
health service interventions, income to support  research institutions and infrastructure, 
development of skills and expertise for Australian researchers and, enhancing the profile of 
Australian research in general (NHMRC Clinical Trial Center proposal to Clinical Trials 
Action Group, 2010; Medicines Australia and Pharmaceutical Industry Council Research and 
Development Task Force, 2010). Local and global pharmaceutical companies, as well as 
clinical and academic investigators initiate and conduct clinical trials research in Australia 
(Medicines Australia and Pharmaceutical Industry Council Research and Development Task 
Force, 2010). Australia has approximately 460 biotechnology companies actively involved in 
the development of human medicines, and more than 60 pharmaceutical companies and about 
154 compounds are known to be in development in Australia (Medicines Australia and 
Pharmaceutical Industry Council Research and Development Task Force, 2010). 
Funding for clinical trials research in Australia comes primarily from the pharmaceutical 
companies who invest approximately about $1 billion a year in research and development of 
new and current medicines already on the market (Medicines Australia Occasional Paper 
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Series 2, 2011). Of this, at least $630 million is spent on clinical trials research per annum 
(2011 Survey of Privately Funded Clinical Research Activity, February 2012). In contrast, 
the NHMRC funded about $100 million for clinical and randomised controlled trials in 2012 
(NHMRC Research Funding 2003-2012). Furthermore, the pharmaceutical clinical trials 
research industry employs almost 14,000 people around the country in a range of highly-
skilled, high paying jobs (Medicines Australia, Occasional Paper 2, 2010). Of those 
employed in this industry, 72% have some sort of post-secondary education and 19% hold a 
Masters or PhD degree (Medicines Australia Member Economic Survey, 2009). The research 
and development investment of pharmaceutical industries is the third largest by area of 
business expenditure in Australia, behind the financial services and mining sectors 
(Medicines Australia, Facts Book 2, 2010). It is quite clear that the clinical research industry 
as a whole is of great economic value to the Australian economy. 
Since the early 1990s the number of clinical trials conducted in Australian has grown 
significantly. Much of the early growth can be attributed to the introduction of the Clinical 
Trial Notification Scheme (CTN) which not only decreased the time taken to start a study in 
Australia (Bourgeois, 2010; TGA, 2001) but also introduced an accurate system of recording 
trial activity. It was mainly during this period that Australia established itself as a preferred 
destination for conducting high quality and cost efficient clinical trials because of advantages 
such as highly trained researchers, good trial start-up times, reliable recruitment, competitive 
costs and a world class medical system (Bourgeois, 2010). Figure 1.1 shows the number of 
clinical trials notifications to the TGA each year from 1998 to 2011 and is indicative of 
clinical trials research activity in Australia annually. 
 
However, in the last five years, there have been changes in the global environment that have 
seen  the cost of research and development escalating rapidly, which in turn has affected 
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Australia’s standing as a preferred destination for conducting clinical trials research 
(Kirkman, 2010). Two other recent challenges facing Australia in conducting clinical trials 
are reductions in the speed of setting up a clinical trial and low patient recruitment numbers 
(Medicines Australia Annual Report, 2010). The reduced investment into clinical trials 
research and development in Australia is most certainly due to increased competition from 
India, China and Latin America where a larger population base provides higher patient 
recruitment and cheaper costs in setting up of clinical trials (Medicines Australia and 
Pharmaceutical Industry Council Research and Development Task Force, 2010). 
Figure 1.1 Number of Clinical Trial Notifications 1998-2011 
 
 
Figure 1.1 shows that the historical growth of clinical trials research in Australia had reached 
a plateau between 2007 and 2011 and may possibly show a reversal of trend. The potential 
loss to Australia in terms of economic value is a significant loss of clinical trial activity and 
investment with more than 2820 trials and projects registered in 2011.  
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To prevent a further decline in investment in clinical trial activity, initiatives need to be 
developed and implemented that specifically increase Australia’s competitive advantage in 
conducting high quality research. Concomitantly, the Australian government has put in place 
a number of initiatives to encourage clinical trials activity in Australia which include 
investing in clinical research as part of its Nation Building Strategy and establishing an action 
group to identify and progress necessary reforms to secure Australia’s competitiveness in the 
global clinical trials research sector. This will be further discussed in chapter two. 
1.2 Clinical Trials Coordinators 
With the sharp increase in clinical trials research activity over the last two decades (as shown 
in Figure 1.1), new roles within the industry have evolved.  One of these is the clinical trial 
coordinator (CTC) role which involves the co-ordination and management of clinical trials. 
Despite a growing presence in the healthcare sector, not a great deal is known about the CTC 
role or those who perform it (Rickards, Roberts & McGrail 2006).  The majority of research 
to date has been undertaken in North America and the United Kingdom, but two studies of 
the CTC role have been conducted in Australia (Roberts, Eastwood, Raunow et al., 2011; 
Rickard et al., 2006).  CTCs play a key role in implementing and managing rigorous and 
ethically sound research in all clinical specialities. The role also encompasses education and 
has a range of caregiver/clinician responsibilities with trial participants. Therefore, CTC 
positions are much more than data collection and administrative support roles (Roberts et al., 
2011; Hill and MacArthur, 2006; Jellen, Brogan, Kuzma et al., 2008). The position requires a 
high level of organisational skill with attention to minute details, excellent communication 
skills and sufficient clinical experience to be aware of possible implications or adverse effects 
associated with the treatment involved in the trial (Fowler and Stack, 2007).  
 
 The professional and clinical skills of registered nurses have been suggested as being  
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complementary to the CTC role and nurses are increasingly being employed into this  role 
(Roberts, Eastwood, Raunow et al 2011; Bell 2009; Grady and Edgerly 2009; Yin 2008; 
Spilsbury, Petherick, Cullum et al., 2007 Rickard et al., 2006; Stephens-Lloyd 2004). Nurses 
have transitioned into clinical trials research in both pharmaceutical and academic settings 
and have become integral members of clinical trials research team (Hill and MacArthur 2006; 
Mueller 2001; Pelke and Easa, 1997). Despite varying position descriptions and job titles, 
nurses transitioning into CTC roles are generally acknowledged as health professionals  
displaying leadership qualities who are able to provide clinical expertise throughout the 
clinical trial process (Nagel, Gender & Bonner 2010; Poston and Buescher 2010; Stephens-
Lloyd 2004). For the purpose of this study, nurses working specifically in clinical trials 
research as clinical trials coordinators will be addressed as clinical trials nurses (CTN). 
 
In Australia, both government organisations and the pharmaceutical industry recognise that a 
highly trained workforce is required for the successful outcome of clinical trials (Petersen, 
2007). It is difficult to obtain an estimate of the number of CTNs in Australia. This is partly 
due to the spread of CTNs across both private (pharmaceutical) and public (hospital) sectors, 
and no national employment database exists. However, it would be reasonable to assume, as 
some reports suggest, that the number of CTNs in Australia has increased over the last few 
years in line with the increased activity of clinical trials research (Rickard et al., 2006; Waller 
2003).  
 
Despite nurses embracing the CTN role, very little is known or reported about their 
involvement or contribution in Australian literature. As such, a greater understanding of the 
role of CTNs in Australia is considered important. This thesis aims to achieve a better 
appreciation and comprehension of the role that CTNs play in Australian clinical trials from 
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the perspective of registered nurses and medical practitioners working in clinical trials 
research. Medical practitioners’ perspective is important to gain as they lead clinical trials 
research and are influential in recruiting CTNs. The researcher is a registered nurse working 
in clinical trials research.  The following section outlines the personal experiences that led to 
this investigation of the role that nurses play in clinical trials. 
1.3 Personal Experience of Clinical Trials Nursing  
I was motivated to commence this project because of my professional experience working in 
clinical trials research. I started working in clinical trials as a registered nurse in the United 
Kingdom (UK). I worked in cardiology trials in the UK and oncology and cardiology clinical 
trials in Australia.  I have found working in clinical trials research a rewarding, exciting and 
stimulating career. There were enormous variations across the three CTN positions I held 
over a period of eight years in terms of how my professional background as a nurse was 
utilised, the degree of contact with patients, my position as a clinical trials nurse, my role in 
the clinical trials team, and professional recognition of my career. My trip to the UK was 
decided after I had completed my Honours degree in nursing in Australia. I chose the UK for 
a number of reasons. Firstly, I noticed that nurses working in clinical trials research were 
more established in the UK, thus enabling me to widen my academic scope. Secondly, the 
nursing practice was similar to Australia and I did not need to sit examinations to prove my 
credentials.  
 
My role as a CTN in the UK involved a range of trial related activities such as recruiting trial 
participants, contributing to the development of the study, providing feedback on how trial 
participants were progressing and often following up on trial participants’ progress and 
outcomes. The follow up often involved discussion of participants’ pathology results, 
education on general health and lifestyle and referrals to other health professionals if needed. 
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I was recognised as an integral part of the clinical trials investigation team and was published 
as the co-author of a paper in an international journal (Sastry, Daly, Chengodu & McCollum, 
2007). During this period, my remuneration was set by the UK Nursing Council and it was 
set to a scale that recognised nurses working in clinical trials research.  
On returning to Australia, I was successful in obtaining another position in clinical trials 
research and was struck by the contrast in how the role operated.  I first worked in oncology 
trials before returning to cardiology trials. The oncology trial position was in a world- 
renowned unit in a large public hospital where international and domestic trials were 
conducted and I was offered the position due to my previous clinical trials research 
experience in the UK. The move to cardiology was motivated by my need to gain further 
experience in another clinical speciality. The key differences between these roles were my 
position title, the portfolio of responsibilities that I held, my involvement in trial recruitment 
and my remuneration scale. 
 
In the oncology unit, my title was initially clinical trials assistant which was subsequently 
changed to clinical research officer without any changes to my job description. My role 
involved working with melanoma patients who had been recruited into an international multi-
centre surgical clinical trial. I managed participants’ follow up visits, often supporting them 
through various stages of their disease and treatments. I was responsible for data collection, 
nursing and research management of the patients I dealt with. The role necessitated a level of 
specialist knowledge of oncology and involved working closely with clinical nurses in 
oncology, allied health professionals, the radiology team, junior doctors and consultants. 
Often my role would overlap and incorporate that of clinical nurse, liaison, educator and 
researcher. The unit was a busy clinical and research centre with multiple trials being 
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conducted, but provided a supportive work environment and ready interaction with staff and 
other colleagues. 
 
After three years working on oncology trials, I moved to a cardiology unit in a public hospital 
as a part-time clinical trials coordinator. It was a small unit compared to the oncology unit I 
had worked in previously, and had comparably smaller staff numbers, however my 
responsibilities here were greater than at the oncology unit. The description of duties 
involved managing a number of trials simultaneously and being responsible for monitoring 
the ethical requirements of these trials. The duties involved recruiting and managing 
participant follow up, liaising between pharmaceutical companies and various hospital 
departments as well as caring for patients, data collection and management, and attending 
audits and investigator meetings for new potential trials. Although it was a busy cardiology 
unit, there was little interaction with other health professionals in the unit and I often worked 
in isolation. 
 
The key difference I noted between my position in oncology and cardiology was that at the 
cardiology trials centre, coordinators were encouraged to attend investigator meetings and 
conferences, and regular meetings were scheduled with the principal investigator to discuss 
trial and patient management. The key difference I noted between my positions in UK and 
Australia was the remuneration. In the UK, I was paid under a nursing scale that recognised 
both my nursing expertise and research skills, however in Australia this was not the case. 
Nurses working in clinical trials in Australia were (and still are) paid at the level that was 
deemed appropriate by the employer.  
The remuneration scale for nurses in the UK is nationally set and monitored by a single 
governing body with varying levels of speciality and levels of clinical and academic 
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experience acknowledged. However, in Australia, the pay scale for nurses varies across the 
country. Different awards and agreements in workplaces, and in all health settings, determine 
the wages and conditions for nurses in Australia.  Awards of Fair Work Australia provide the 
legal minimum for wages and working conditions in Australia but wages for nurses vary 
depending on the relevant State/Territory and the specific area of nursing 
(http://anmf.org.au/pages/wages-conditions). Having said this, there is no award for nurses 
working in clinical trials. In most states, CTNs are employed under a nursing award that is 
related to their clinical specialty and experience not their experience in clinical trials which is 
often determined by their employers. However, Victoria is working towards an award and 
pay scale for CTNs. 
In Victoria, there is a pay scale for nurses working in research which is titled Research Nurse, 
graded at either level 3A or 3B with only 2 grade increments within the respective level 
(http://www.anmfvic.asn.au). The Victorian Association of Research Nurse with Australian 
Nursing and Midwifery Federation are currently in the process of classifying and 
streamlining the role and title (http://anmfvic.asn.au/sigs/news).  
 
It was while working in cardiology that I began to reflect on my role as a registered nurse 
working in clinical trials and this led me to question if other nurses in similar roles to mine 
also had questions about their role. After making some inquiries I realised that many of my 
colleagues were also expressing dissatisfaction with their role as CTNs. They had similar 
questions about their scope of practice, their remuneration as well as their career pathway. I 
decided to pursue this matter further by reviewing available literature and discovered that 
there was very little research into the role of nurses working in clinical trials research and 
only a small number of studies conducted in Australia. There was a dearth of literature 
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concerning role recognition and no in-depth exploration of the CTN role. These findings led 
me to the primary research question for this thesis. 
1.4 Research Question 
What is the role of registered nurses in clinical trials research in Australia? 
1.5 Research Aim 
To examine and describe the role of nurses working in clinical trials research in Australia 
from the perspective of CTNs and medical practitioners working in this area.  
1.6 Significance of the Research 
As noted above, the Australian government and pharmaceutical industry has made significant 
investment in healthcare research and significant amounts of funding have been devoted to 
infrastructure and human resources supporting research. Furthermore, more clinical research 
is being conducted in Australia, particularly clinical trials, leading to an increase in the 
number of trial-specific and clinical trial coordinator roles. Although the CTC role is 
occupied by a range of health professionals, registered nurses are the largest group making a 
transition from the clinical setting to the trials setting. Despite this, research examining and 
describing the roles of CTNs is limited. 
This research will describe the potential contribution of the CTN to the conduct and 
management of clinical trials research in Australia. The aim of this study is to facilitate better 
understanding of CTNs’ role in Australia which in turn would assist with the development of 
the role among the nursing profession and potential employers.  
1.7 Outline of the Thesis 
Chapter two is divided into two sections. Section A explores current literature in relation to 
the clinical trials research industry and recent developments in clinical trials research in 
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Australia. This provides a critical context for the study presented in this thesis. Section B, 
presents a review of current literature focusing on the critical aspects of nurses working in 
clinical trials research and a critical analysis of the role of nurses in clinical trials research 
both in Australia and internationally.  
 
Chapter three describes Gadamer’s hermeneutic philosophy, the method chosen for this 
study, and its suitability in exploring the roles of clinical trials nurses. This chapter also 
outlines ethical considerations and how the study was conducted, including a description of 
the study design, participants, data collection and analysis and steps taken to ensure 
methodological rigour.  
 
Chapter four explores the qualitative interpretation of the experiences of CTNs working in 
clinical trials research in Australia as emerging from the data analysis. Chapter five considers 
and discusses the findings of this study including implications of this research for nursing, 
while recommendations for further research and comments on the limitations of the study are 
presented in Chapter six. 
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Chapter 2: Literature Review 
2.0 Introduction 
To provide detailed background to this study, two areas will be examined in this chapter. 
First, recent developments in clinical trials research in Australia will be explored as this 
provides critical context for the study presented in this thesis. Clinical trials research is 
defined and described. The advantages and disadvantages of conducting clinical trials and the 
associated ethical considerations will be discussed.  Finally, a brief overview of clinical trials 
research conducted in Australia is presented. Next, a literature review focusing on the critical 
aspects of nurses working in clinical trials research and a critical analysis of the role of nurses 
in clinical trials research both in Australia and internationally is presented. The critical 
analysis of the literature will include role recognition, educational qualifications, professional 
issues and career pathways. 
2.1 Overview of Clinical Trials Research 
Well-designed clinical trials encompass a specific type of methodological approach that 
enables researchers to test an idea, drug or intervention.  
Friedman and colleagues (2010, p 2) define a clinical trial „as a prospective study comparing 
the effect and value of intervention(s) against a control in human beings.‟ Pocock (1983) 
describes a clinical trial as a term applied to planned experiments which involve patients and 
are designed to develop treatment for future patients with certain medical conditions. For the 
purpose of this research study, only clinical trials involving human beings will be considered. 
Research involving humans is regulated in many ways and at many levels. Clinical trials are 
guided and implemented according to a clinical trial protocol. The protocol contains 
information on scientific evidence that supports the trial, how the trial will be conducted 
including its design, eligibility criteria of the participants and the outcomes that are to be 
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measured. Clinical trial protocols are sent to regulatory bodies such as Clinical Trials 
Registries as well as to ethics committees for review and approval (Kerr, Knox & Robertson, 
2008). Regulatory requirements in Australia apply through Commonwealth and state 
legislation, dealing with a range of matters such as the rules governing the conduct of clinical 
trials for therapeutic goods, radiation safety, use of human tissue samples and privacy of 
personal health information (Bloom and Frew 2009). In addition to this legislative regulation 
of research, a wider concept known as research governance directed to organisational 
frameworks and quality standards rather than just mandates and prohibitions is also practiced 
(NHMRC 2007; Bloom and Frew 2009). Research governance takes an expansive approach 
to the regulation of human research encompassing frameworks and systems over ad hoc 
policy making. Research governance promotes standards for the conduct of research, as well 
as regulatory requirements, mechanisms for dealing with research misconduct and definition 
of roles and responsibilities of all parties involved in research ensuring the promotion of 
quality research (Bloom and Frew, 2009). 
 
Clinical trials research is funded by pharmaceutical companies, national research bodies such 
as the National Health and Medical Research Council of Australia, charitable foundations and 
private donations. Trials are usually conducted in hospitals, medical centres, universities, 
private clinical laboratories and research facilities. Individuals from varying specialities are 
involved in the design, conduct and management of clinical trials research. The clinical trials 
research team includes, but is not limited to, scientists, medical practitioners, nurses, other 
health care professionals, epidemiologists, statisticians, the sponsor organisation, ethics 
committees and patients and carers (Kerr, Knox & Robertson, 2008). Clinical trials are 
conducted in a wide range of clinical and disease contexts and vary in purpose, aims and 
objectives and design.  Five broad categories, relating primarily to the study’s clinical 
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objectives, are generally used for classifying clinical trials.  These categories, summarised in 
Table 2.1 are: treatment, prevention, diagnostic, screening and quality of life trials.  
Table 2.1: Categories of Clinical Trials Research 
 
Treatment trials  Test experimental treatments, new combinations of drugs, new 
approaches to surgery or radiation therapy 
Prevention trials  
 
 
Evaluate approaches to prevent disease in people who have never 
had the disease or to prevent a disease from returning. These 
approaches may include medicines, vaccines, vitamins, minerals, 
or lifestyle changes. 
Diagnostic trials  Conducted to find better tests or procedures for diagnosing a 
particular disease or condition. 
Screening trials Test the best way to detect certain diseases or health conditions. 
Quality of Life trials 
or Supportive Care trials 
Explore ways to improve comfort and the quality of life for 
individuals with a chronic illness. 
Adapted from information accessed from clinicaltrials.gov. Accessed on the 21
st
 April 2011 
In addition, clinical trials research is often divided into four phases (I – IV) relating to the 
clinical development phases of a drug or device.  The trials conducted at each phase have a 
different purpose and help investigators answer different questions (Table 2.2). Trials 
evaluating non-pharmacologic agents can be divided similarly and are split into phase II and 
III trials, with phase II being mainly a pilot study and phase III largely consisting of 
randomised controlled trials are where the intervention is assessed for its effectiveness and its 
value in clinical practice (Friedman et al., 2010).  
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Table 2.2: Clinical Trial Development Phases I-IV 
 
Phase Description Example of Study 
Population 
Phase I Researchers test an experimental drug or treatment in a small 
group of people for the first time to evaluate its safety, 
determine a safe dosage range, and identify side effects.   
20-80 people; healthy 
volunteers or people 
with disease of 
interest 
Phase II The experimental study drug or treatment is given to a larger 
group of people with the disease of interest to see if it is 
effective and to further evaluate its safety. 
100-300 people 
Phase 
III 
The experimental study drug or treatment is given to large 
groups of people to confirm its effectiveness, monitor side 
effects, compare it to commonly used treatments or placebo 
in a randomised controlled study design, and collect 
information that will allow the experimental drug or 
treatment to be used safely. 
1000-3000 people 
Phase 
IV 
Post marketing studies to collect additional information 
including the drug's risks, benefits, and optimal use. 
General population 
 
Adapted from information accessed from clinicaltrials.gov. Accessed on the 21
st
 April 2011 
Despite the aforementioned breadth of clinical contexts and objectives, as well as the range of 
trial types, there are common characteristics of clinical trials which distinguish this research 
approach from other methods. Firstly, a clinical trial is a prospective study design in which 
participants are followed forward in time from a clearly distinct point at which they are 
identified, selected and observed from the point of initiation (Friedman et al., 2010).  
 
Secondly, clinical trials are conducted in controlled environment, allowing for control of key 
variables such as the initiation of the intervention and measurement of covariates and 
confounders, helping to minimise bias (Piantadosi, 2005). Firstly, participants should be 
selected randomly from the population of interest. Randomisation in group allocation further 
strengthens the design by avoiding bias inadvertently introduced by selecting which 
participants receive which treatment (Friedman et al., 2010). Allocation concealment is 
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important for ensuring successful randomisation (Beller, Gebski & Keech 2002; Forder, 
Gebski & Keech 2005) and maintaining blinding after randomisation is important for 
avoiding bias (Forder, Gebski & Keech 2005).  
 
Clinical trials are not merely observational studies but experiments that are measuring 
outcomes (Friedman et al., 2010). Therefore, clinical trials will always have some form of 
intervention, which may be a single or combination of diagnostic, preventive or therapeutic 
drugs, devices or procedures (Friedman et al., 2010).  
2.1.1 Benefits and Limitations of Clinical Trials Research 
Well-designed clinical trials have considerably advanced knowledge in both clinical practice 
and in understanding of the treatment of disease, benefiting both current and future patients 
(Kerr, Knox & Robertson, 2008). The testing of a new drug or intervention in a systematic 
way with bias minimised to the greatest possible extent enables researchers to interpret the 
results of a study with a greater degree of confidence. The phased approach to implementing 
an intervention in clinical trials research reduces risk to the participants builds on evidence 
and tests feasibility as the trial  progresses through each  phase, as illustrated in Table 2.2. 
Phase III and IV clinical trials are unable to be progressed without evidence from phase I and 
II to support the benefits and safety of an intervention (Piantadosi, 2005), thus reducing risk. 
Clinical trials are conducted in a highly regulated and rigorous way so that investigators can 
measure the effects of each treatment being tested on patients with a degree of precision and 
confidence (Friedman et al., 2010; Piantadosi 2005). In addition to this, the use of an 
internationally acceptable standard and clinical protocol enable replication of clinical trials so 
that results can be tested and confirmed in different populations (Friedman et al., 2010; 
Piantadosi 2005). 
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A critically important factor when evaluating new medicines and treatments through a 
clinical trial is the incidence of adverse effects or complications due to the intervention 
(Friedman et al., 2010). Sponsors and investigators are required to closely monitor the 
adverse effects of treatments according to strict regulatory reporting guidelines, which 
include immediate reporting of any adverse effects to the appropriate regulatory body and to 
ensure that all actions taken are recorded in clear and concise manner. This monitoring 
continues after the drug has become available for sale (Phase IV), with further identification 
of side effects sometimes leading to the withdrawal of a treatment or drug from the market. 
An example of this is the drug Rofecoxib (VIOXX®), which was withdrawn from the market 
in 2004 due to threatening and fatal side effects discovered through a prospective, 
randomised, placebo-controlled clinical trial conducted by the company that manufactured 
the drug (Federal Drug Authority 2009). 
In Australia, the Therapeutics Goods Administration (TGA) administers the Therapeutic 
Goods Adverse Drug Reaction Act 1989, a legislation which provides a framework for a risk 
management approach allowing the community to have timely access to therapeutic goods 
which are consistently safe, effective and of high quality (www.tga.gov.au accessed 21st 
September 2011). In essence, the conduct of clinical trial research offers investigators and 
sponsors an opportunity to evaluate their product before and after it reaches the public, 
enabling efficient and safe delivery of new therapeutic interventions. 
Limitations and challenges to conducting clinical trials research include  the time that it takes 
to complete a clinical trial,  the challenges of timely recruiting from a specified population  
and the duration of patient follow up. Regulatory and ethical approvals also take time and 
may be complex (Friedman et al., 2010; Piantadosi 2005). Other barriers are the cost of 
setting up and conducting clinical trials, the difficulty of studying rare outcomes in large 
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cohorts and issues with randomisation (Friedman et al., 2010; Piantadosi 2005). Issues with 
randomisation can include poor judgement in the choice of method, design errors in 
implementing the method and human error during conduct of clinical trials (Downs, Tucker, 
Christ-Schmidt & Wittes, 2010).  
2.1.2 Ethical Considerations and Governance in the Conduct of Clinical Trials Research 
The rapid increase in the number of clinical trials, particularly those sponsored by 
pharmaceutical companies and public funding by governments has placed clinical research 
and in particular clinical trials research under scrutiny (Friedman 2010; Piantadosi 2005). To 
ensure investigators preserve both integrity and accountability in the conduct of trials, clinical 
research should be underpinned by the imperative that investigators uphold and protect 
patients’ safety and interests. The ethical framework guiding the conduct of clinical trials is 
shaped by both global and national guidelines. Research governance provides a framework 
for principles, requirements and standards for the conduct of clinical trials research. The 
framework aims to ensure that the scientific quality, ethical acceptability and safety of trials 
conducted in various institutions and organisations are preserved.  
Institutions carrying out clinical research in Australia must have policies and procedures in 
place to meet national ethical, legal and research practice standards (NHMRC, 2007). Despite 
the stringent standards demanded by ethics and research governance frameworks, there are a 
number of previous clinical research studies involving blatant disrespect for patients’ rights 
and welfare. For example, investigators in the Tuskegee study in Alabama, USA (1932-1972) 
studied groups of impoverished black males who had been diagnosed with syphilis and failed 
to give these patients penicillin even after penicillin was validated as a cure for the disease.  
In the New Zealand Cervical Cancer Experiments in 1970, treatment was withheld from 
women diagnosed with cervical cancer without their consent, monitoring of outcomes was 
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inadequate, and the study was not stopped when clinicians raised their concerns (NHMRC, 
2007). These incidences have led to a global movement to ensure standards of practice are 
followed and maintained through the introduction of a comprehensive informed consent 
process (www.ich.org). 
The current ethical framework governing clinical research began with the establishment of 
the Nuremberg Code. Following World War II and the discovery of unethical experiments 
conducted in Nazi concentration camps, the Code was promulgated with the goal of 
protecting human subjects in biomedical research. The next important step was the World 
Medical Association’s adoption of the Declaration of Helsinki in 1964. The Declaration, 
which has since been expanded several times, defines ethical responsibilities of researchers 
using human volunteers in their research (www.wma.net). In 1990, the International 
Conference on Harmonisation (ICH) was started to progress international standards for 
conducting research, particularly in clinical trials, and for assessing the safety and efficacy of 
new drugs (www.ich.org). These global guidelines guide the current practice of clinical 
research in countries across the world by providing standards of ethical conduct and 
protection of patients in research.  
 
In Australia, the NHMRC, Australian Research Council and Australian Vice Chancellors 
Committee developed the National Statement on Ethical Conduct in Human Research to 
guide researchers in ethical human research (NHMRC 2007). The development of the 
national statement reflects and supports global guidelines already in place. The National 
Statement specifies that participants must be accorded the respect and protection that is due to 
them. Furthermore, the research involved must be of benefit to the community (National 
Statement on Ethical Conduct in Human Research 2007). In addition to guiding the ethical 
conduct of research and the dissemination of research findings, the National Statement is 
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used by institutional ethics committees to guide the ethical review of research (NSECHR 
2007).  
The National Statement specifies that the relationship established by researchers and 
participants are based on values like respect for human beings, research merit and integrity, 
justice and beneficence which lead to trust, mutual responsibility and ethical equality 
(NSECHR, 2007). Respect for the individual or participant is reflected in the principle of 
informed consent, which incorporates the individual’s right to select to be involved in the 
research (consent) and the need to be fully informed to enable them to make this decision. 
The process of consent allows the participant to make an autonomous decision in regards to 
participation that is required to be respected and adhered to by the clinical trials research 
team ( Gallin and Ognibene, 2012).  
Ethics and research governance play an integral role in ensuring that clinical trials research is 
conducted with participants’ welfare being of utmost importance. Ethics committees provide 
advice and set guidelines relating to the conduct of clinical research involving humans as well 
as promoting debate on health ethics issues and monitoring international development in 
health and research ethics (www.nhmrc.org.au). Research governance ensures that standards 
of practice are maintained. Standards of practice are defined by the ICH and described by the 
term ‘good clinical practice’ (www.ich.org). 
In 1996, ICH published a set of guidelines for good clinical practice which is currently used 
as the international ethical and scientific quality standard for designing, conducting, 
recording and reporting trials that involve the participation of human subjects (Guideline for 
Good Clinical Practice E6 (R1), 1996). Good clinical practice provides assurance to all 
parties concerned that the rights, safety and wellbeing of trial subjects are protected, 
consistent with principles that have their origins in the Declaration of Helsinki, and that 
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clinical trial data are credible (www.tga.gov.au). It is a major requirement of good clinical 
practice is to ensure that staff working in clinical trials research have achieved and maintain 
good clinical practice (www.ich.org and www.tga.gov.au). This is to ensure that clinical trials 
research are conducted safely and that data collection and results have credibility. The 
responsibility to oversee the conduct of clinical trials research is assigned to the investigator. 
In fact, within the Guideline for Good Clinical Practice E6 document, very little, if any is 
mentioned of the role a nurse plays in clinical trials research conduct despite the critical role 
that nurses play in the conduct and management of clinical trials research.  
 
In summary, it is crucial that research is carried out ethically and scientifically to ensure the 
safety and welfare of participants. In Australia, ethical research conduct is mandated by a 
National Statement which is informed by a global framework of declarations and codes of 
conduct. Clinical trial researchers and institutions at which clinical trials research is being 
conducted are responsible for understanding and complying with these requirements.  
2.2 Clinical Trials Research in Australia 
Clinical trials research represents a key research activity in Australia with the clinical trials 
research sector worth approximately $1 billion per annum to Australia with direct foreign 
investment of over $450 million per annum (Clinical Trial Action Group, 2011). Conducting 
clinical trials research in Australia has led to economic benefits for the country with health 
research and development providing returns of 117% to Australia, exceeded only by mining 
(159%) and wholesale/retail (438%) (Access Economics, 2008). Investment in clinical 
research comes from both the private and public sectors with the main sources of funding for 
pharmaceutical research coming from commercial entities (Medicines Australia and 
Pharmaceutical Industry Council Research and Development Task Force, 2010).  
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The conduct of clinical trials research in Australia involves multiple sectors including the 
pharmaceutical and biotechnology industries, research institutions, hospitals and government 
departments. The NHMRC, Australia’s peak body for supporting health and medical 
research, disperses considerable Commonwealth funding for clinical trials research 
(http://www.nhmrc.gov.au). The commitment of the government to research funding has 
helped facilitate the growth of clinical trials research. Other factors that have contributed to 
the growth of clinical trials research in Australia are the availability of Good Clinical Practice 
(GCP) trained staff able to manage and complete clinical trials research within time lines and 
a strict regulatory framework governed by the TGA (http://www.tga.gov.au).  
 
The TGA is responsible for regulating therapeutic goods including medicines, medical 
devices, blood and blood products and evaluates therapeutic goods before they are marketed. 
The TGA also monitors products once they are on the market, as well as assessing the 
suitability of medicines and medical devices for export from Australia 
(http://www.tga.gov.au). The TGA continually monitors and evaluates the safety and efficacy 
of therapeutic products and manages any risks associated with individual products 
(http://www.tga.gov.au). To this effect, the TGA ensures that therapeutic goods available for 
supply and consumption in Australia are safe and fit for their intended purpose by ensuring 
‘pre-market assessment; post-market monitoring and enforcement of standards; and 
licensing of Australian manufacturers and verifying overseas manufacturers' compliance 
with the same standards as their Australian counterparts.’ (http://www.tga.gov.au). The 
regulatory framework that TGA has adopted when deciding whether to approve a medication 
for supply and the conditions that might be imposed on that approval is a risk-based approach 
to regulation (http://www.tga.gov.au). 
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In essence, both TGA and NHMRC work together to address protection of research 
participants, the safety and quality of research, privacy and confidentiality, financial integrity, 
legal and regulatory matters, risk management and monitoring arrangements and promote 
good research culture and practice (www.nhmrc.gov.au). 
In response to a number of challenges facing the Australian clinical trials industry, the federal 
government established the Clinical Trials Research Action Group (CTAG) action group to 
identify and progress reforms for improving Australia’s competitiveness in the clinical trials 
research sector (Department of Innovation, Industry, Science and Research, 2009).  These 
challenges include the comparatively high cost of setting up clinical trials research in 
Australia compared to other countries within the Asia Pacific region, delays in ethical review, 
and patient recruitment targets not being met, especially in Phase III trials.   
 
The CTAG proposed a number of initiatives to meet the aforementioned challenges. A key 
recommendation was the rapid initiation of a single ethical review process, the 
Harmonisation of Multi-Centre Health Ethical Review (HoMER), to minimise delays in 
ethical reviews. HoMER is a collaborative research project that was developed by the 
NHMRC to address the problem of multi-site ethical review. At present, the need to seek 
multiple ethical reviews across more than one hospital and state jurisdiction is a key problem 
and contributes significantly to delayed timelines for research. CTAG called for a national 
system of ethics reviews for multi-centre clinical trials in public health organisations by 
March 2012 (CTAG, 2011).  
Other recommendations in regards to reducing delays include introducing a policy on clinical 
trials research that provides incentives to reach ethics and governance review within 30 days. 
For this service, sponsors would pay a defined additional amount to support increased 
efficiency and ensure a two months maximum timeframe for ethics and governance review 
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(CTAG, 2011) prior to trial commencement. However, Australia's national newspaper (The 
Australian) reported in May 2012 that changes have been slow to be adopted and 
implemented by the federal and state governments. Only three states, NSW, Queensland and 
Victoria have moved to streamline ethical review, and while single ethical review was 
achieved for study sites in public hospitals across all three states from early 2012, a national 
system is still not in place (http://www.theaustralian.com.au, May 22, 2012). 
 
In its pursuit to maintain best health care delivery, the Australian federal government has now 
initiated a strategic review to ensure that Australia remains at the cutting edge of health care 
delivery. The McKeon Review  'will take into account broader Government policy, including 
the Government‟s fiscal strategy, and will focus on optimising Australia‟s capacity to 
produce world class health and medical research to 2020' (http://www.health.gov.au).The 
Review will also pay close attention to a changing burden of disease, resources required for 
health research, and the dynamic nature of research - which includes infrastructure and better 
translation of research to clinical practice (http://www.health.gov.au). One of the matters that 
the review panel is looking closely at is how to attract, develop and retain a skilled research 
workforce which is capable of meeting future challenges and opportunities 
(http://www.health.gov.au). 
2.3 Research workforce in Australia 
The issue of developing and retaining a skilled research workforce is not new for Australia.  
Developing research workforce capacity was a recommendation from CTAG and was tabled 
by the NHMRC, Clinical Oncological Society of Australia (COSA), Medicines Australia and 
other organisations in their initial submission to both CTAG and the McKeon Review. The 
CTAG report provided a broad overview of the need for approaches to improve the timeliness 
of clinical trial approvals, the benefits of e-health for clinical trials, improving patient 
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recruitment and the level of support for clinical trials networks 
(http://www.innovation.gov.au) all of which can only be achieved with a strong skilled 
workforce. COSA in their comment on the 2011 Strategic Roadmap for Australian Research 
Infrastructure Exposure Draft (July 2011) insist that funding be secured to support the 
recruitment and retention of skilled clinical trials workforce which will include medical and 
science graduates, trial coordinators, data managers and biostaticians. A skilled workforce is 
required if the process of ethics and governance in clinical trials research is to be closely 
observed and complied with. Furthermore, a highly efficient workforce will ensure that 
clinical trials research conduct continues to adhere to the standards of GCP. 
 
In light of this call for investment in clinical research infrastructure, there are major 
implications for nursing. Anecdotal evidence suggests that nurses have held roles in clinical 
research that has combined the tasks of trial coordination with patient recruitment, education, 
data collection and patient care. Growth in clinical trial activity in Australia due to the 
recommendations of CTAG will ultimately lead to a demand for growth in recruitment and 
retention of nurses working in the clinical trials research field. Therefore there is a need to 
comprehensively understand and define the professional scope of nurses working in this role.  
 
SECTION B 
2.4 Literature Review of Clinical Trials Research Nurse Role 
A literature review was undertaken to describe the current role of clinical trials research 
nurses in Australia, to explore professional issues surrounding this role and to identify gaps in 
the literature in regards to the clinical trials research nurse role. The literature review 
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provided a basis for the context of the interview questions that is part of the qualitative 
method for this research.  
The process of conducting this literature review is outlined in Figure 2.1, followed by a 
detailed discussion of the role of clinical trials research nurses based on findings from the 
literature. This literature review will focus on the numbers of Clinical Trials Nurses or CTNs 
in the workforce, elements of their role, specific professional issues and career pathways. 
 
 
Figure 2.1: Literature Review Process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Articles in languages 
other than English 
(exclude 5) 
Articles published 
before 1990  
(exclude 4) 
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directly to research 
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Review of full text 
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Final number 
included 
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Publications 
identified 
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The search strategies employed were designed to identify and collect as many relevant 
publications as possible for the review and used the following keywords: clinical trials 
research nurses, clinical trials research, research coordinators, research nurses, clinical 
research nurse, clinical trial coordinators, data managers and nurses‟ role in clinical trial, 
as well as appropriate combinations of these terms. A systematic search was carried out in 
four databases, CINAHL, MEDLINE, PUBMED and Google Scholar which yielded a total of 
473 publications between 1976 and 2013 (Figure 2.1). This included five articles found using 
the find ‘similar articles’ and ‘link to similar articles’ functions when a related article in any 
of the databases was identified and a number of papers identified from citations in other 
journal articles as well as conference presentations. 
 
An abstract review of the 473 publications was undertaken and it was noted that there were 
four articles discussing the role of nurses in clinical trials research prior to 1990. However, 
more interest is noted in the role after 1990, especially in North America where the bulk of 
articles were found. After excluding papers that were not directly relevant to the search 
question and five articles that were not written in English, a decision to also exclude four 
articles published prior to 1990 was undertaken because of the emergent nature the role 
before this time (Figure 2.1). The reference lists of the remaining articles were examined to 
identify any publications that were not detected in the literature search. Additional searches 
of the above databases using the names of the authors known to have published on the topic 
were also conducted.  
 
Following the initial review, a total of 132 full text articles were retrieved and reviewed in 
detail. The literature regarding the role of the registered nurse in clinical trials research was of 
variable quality and lacked empirical contributions and a majority of the articles consisted of 
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expert opinion. Of the 141 papers reviewed, 25 papers were identified as being empirically 
based research for which questionnaires and surveys were used to gather data and five journal 
articles using systematic literature reviews to address the role of registered nurses in clinical 
trials research were retrieved. Of the final 30 studies and articles included in this review of 
literature, nine studies focused on the CTN role within particular clinical specialities, for 
example oncology. Others published from the 1990s and onwards discuss the role of CTNs 
more broadly; for example, issues of how the role fits into the clinical trial research context, 
career structure, educational needs and ethical responsibilities towards patients and trial 
management. 
 
This review of the literature indicates a plethora of position titles used for nurses working in 
clinical trials research and include: research nurse, clinical research nurse, study coordinator, 
trial coordinator and data manager. The latter position titles clearly indicating that persons 
other than nurses occupy these roles. A brief and informal search for positions in clinical 
trials research such as the Australian employment website www.seek.com.au also produced 
various titles for jobs requiring nurses to coordinate trials.  This finding was also repeated 
when searching for clinical trials research positions through health organisation and 
recruitment agency websites in Australia. The position title encountered most frequently was 
that of ‘clinical research coordinator’ or ‘clinical trials coordinator’. 
 
Table 2.3 presents a summary of the five articles which used a systematic literature review 
method to explore the role of nurses in clinical trials research. One is from New Zealand, two 
from USA and two from UK; none are from Australia. Three of the authors conducted their 
review to ascertain if the role of the nurse in clinical trials research is comparable to that of 
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clinical nurse specialist while the other two reviewed literature to determine the definition 
and explore the role of nurses in clinical trials research.  
Table 2.3: Summary of Systematic Literature Review, exploring Nurses working in 
Clinical Trials Research 
 
Author Year Country Description Conclusion 
Bell 2009 New 
Zealand 
To define and describe the 
role of research nurses and to 
explore issues surrounding 
the within the context of New 
Zealand 
The role of research nurses is in 
transition, needs career structure, 
education and training and 
building a network in New 
Zealand. 
Bird and 
Kirshbaum 
2005 UK To explore the role of the 
clinical research nurse in 
cancer care and be considered 
at advanced practice 
Advanced practice within clinical 
research nursing is possible and 
provides further level of career 
development that may facilitate 
movement between research and 
clinical practice 
Ocker and 
Pawlik 
Plank 
2000 USA Evaluation of the research 
nurse role to develop and 
integrate the role within an 
oncology research program 
Findings provide a framework for 
evaluating the roles of registered 
nurse personnel in a clinical 
setting 
Raja-Jones 2002 UK To compare the role of the 
clinical research nurse to 
clinical nurse specialist 
No available empirical evidence 
examining the role of clinical 
research nurse in UK and how the 
role fits into clinical specialist 
nursing. There remains a lack of 
agreement to the definition and 
educational preparation of clinical 
nurse specialist. 
Raybuck 1997 USA Discussion of the 
multidimensional role of the 
research coordinator and the 
contributions that the clinical 
nurse specialist brings to the 
role of research coordinator 
Advanced educational preparation 
of the research coordinator is 
needed and the role requires an 
advanced practice nurse with the 
ability to apply knowledge, skills 
and experience autonomously to 
complex health situations. 
 
Table 2.4 (Appendix E) presents a summary of the remaining 24 studies that present 
empirical data. These were published between 1993 and 2012. Of the 25 papers, eleven 
studies used descriptive quantitative analysis, six studies used focus groups, three studies 
used interviews, two used both surveys and focus groups for questionnaire development, 
another used documentary analysis and two studies used a mixed methods approach. The 
topics addressed included: roles, responsibilities, career prospects, rewards and challenges of 
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position, job satisfaction, and research misconduct by research nurses. The sample sizes of 
these studies ranged from 9 to 312, with 20 of 25 studies having a sample size of less than 
100 participants. These studies have been published in peer reviewed journals. 
 
The participants in the research studies reviewed were always nurses in clinical trial 
coordination role except for three studies which included principal investigators, patients and 
other professional background in the role of clinical trial coordination. One, a study from 
South Korea which  included principal investigators as participants in determining the roles, 
proficiency and qualification of registered nurses working in clinical trials research (Jeong et 
al., 2007).  Another study, interviewed patients, principal investigators and registered nurses 
to investigate how the researchers and subjects who participate in clinical trials understand 
the contribution of nursing care to research (Easter et al., 2006). The third study conducted by 
Loh and colleagues, (2002) interviewed data managers whose backgrounds were varied 
health professionals. 
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2.5 Elements of Clinical Trials Nurse Role 
The role of the clinical trials nurse role (CTN) has evolved significantly in the last 30 years 
from data collection to a more specialised role requiring specialised knowledge of managing 
and coordinating clinical trials (Oncology Nursing Society (ONS) 2010; Rickard et al., 2006; 
Hill and McArthur 2006; Raja Jones 2002; McEvoy et al., 1991). CTNs work in a wide range 
of clinical and research settings with roles that now encompass day to day data collection, 
complex study coordination and often leadership and management positions as well (ONS 
2010; Bell 2009; Rickard et al., 2006; Bird and Kirschbaum 2005).   
 
Several studies have systematically examined the activities performed by CTNs as described 
in Table 2.3 and Table 2.4 (Appendix E). The activities identified by these studies 
(summarised in Table 2.5) highlight the wide range of responsibilities in coordinating the day 
to day conduct of clinical trials and the attributes, knowledge and skills required for this role. 
Table 2.5 shows that the responsibilities of CTNs appear to focus on three main areas:  the 
patient, the principal investigator and the conduct of the study (Study Sponsor). Another 
important trend noted from the literature review is the range of job titles and diversity of roles 
that registered nurses working in clinical trials research undertake (ONS 2010; Bell 2009; 
Rickard et al., 2006). 
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Table 2.5: Responsibilities of Clinical Trials Nurse 
 
 
 
 
 
 
 
 
 
 
2.5.1 Range of CTN Job Titles  
The findings of the literature review emphasise the diversity of the CTN role in terms of 
varying job descriptions and ambiguous job titles and roles (Nagel et al., 2010; Bell 2009; 
Rickard et al., 2006; Stephen-Lloyds 2004).  The results of the review, supplemented by 
searching internet job sites, underscores the notion that job titles have not changed over time 
and contribute to making the progression and identification of the role challenging. The issue 
is further compounded by the use of generic titles, for example, ‘clinical trials coordinator’ – 
a role which can be filled by health professionals other than nurses. Therefore it is not clear 
how many nurses are in the CTN role in Australia and what their role actually entitles. 
 
In Australian clinical trials, the actual title given to a nurse varies and may include research 
nurse, research coordinator, clinical research coordinator, research clinician, or clinical trials 
Patient 
 
Recruiting patients 
Coordination and follow up 
patients 
Managing adverse events 
Administering and monitoring 
drug/device 
Clinical care 
Educating patients 
Resource for patient 
Data collection and management 
Principal Investigator 
 
Informed consent 
Reporting of adverse events 
Facilitating relationships 
with patient 
Staffing responsibilities 
Financial responsibilities 
Study Sponsor 
 
Preparing regulatory 
submissions 
Monitoring of study 
liaison 
Clinical Trials Nurse 
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coordinator. Regardless of the title, nurses employed to work in clinical trials develop, 
coordinate, and implement research and administrative strategies essential to the successful 
management of research conducted by principal investigators (PIs). Nurses perform a variety 
of duties involved in the organization, oversight, documentation, and compilation of clinical 
research data (Fowler and Stack 2007). 
 
Rickard and colleagues (2006) reported 21 different job titles from 49 respondents in their 
study conducted in Australia and New Zealand. Nineteen participants were called Research 
Coordinator, six used specialty specific derivations such as ICU Research Coordinator, two 
were called Clinical Research Coordinator and six participants used the title Research Nurse. 
Other titles used were Manager, Officer, Fellow, Nurse, and Assistant. Four respondents 
mentioned using alternative or combined titles such as Quality Improvement/Clinical Trial 
Coordinator and one reported no formal title. In addition, 31% of participants in this study 
reported absence of a formal job description. The studies of both Nagel et al (2010) and Rico-
Vilademoros et al (2004) also reflect the same variations as reported by Rickard and 
colleagues with respect to variation in position titles for nurses working in clinical trials 
research. 
  
Other literature on role titles in Table 2.4 (Appendix E) mirrors the findings from the 
empirical evidence (Deave 2005; Raja Jones 2002; Loh et al., (2002); Mueller (2001); 
Xanthos et al., (1998); White-Hershey & Nevidjon, (1990)). Johnson and Stevenson (2010) 
and Deave (2005) both discuss how the term nurse researcher and researcher are used 
interchangeably. Deave (2005) defines the nurse researcher as someone who is based in a 
university department conducting research related to nursing who has research fellow status, 
while a research nurse is a nurse working in clinical research, coordinating and managing 
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clinical research. Johnson and Stevenson (2010) describe the differences between the two 
titles, stating that the skill set that is utilised and required are different between the two 
positions as CTNs not required to hold academic research qualifications.  
 
In the Australian context, Waller (2003) outlines three definitions for research nurse and 
suggests that a nurse who is working on a particular project assisting the principal 
investigator in data collection and management involving patients on a pharmaceutical trial is 
comparable to a clinical trials research coordinator. However, in light of the findings of 
Rickard et al., (2006) reported above, the title of ‘research nurse’ appears to be a generic title 
used for nurses working in all clinical research settings.  
However, the definition of the CTN role is further complicated by staff without a nursing 
background also filling roles in clinical research, often with the same titles (for example, 
clinical research coordinator) (Rico-Vilademoros et al., 2004; Loh et al 2002). The variety of 
job titles used indicates an ambiguous but potentially multi-faceted role that is neither fully 
understood nor able to be accurately attributed to health professional groups engaged in the 
role. According to the literature, this situation could lead to uncertainty in accountability and 
responsibility, as well as a poorly defined career structure for CTNs (Bell 2009 and Simpson 
2006). 
 
A significant number of CTNs have no job description according to the assessment of the 
literature.  Rickard and colleagues (2006) and Simpson (2006) found that 31% and 12% of 
their respondents, respectively, had no job descriptions. Another study reported that 72% of 
its respondents had job descriptions, but only half of these were an accurate reflection of their 
CTN duties (Hill and MacArthur, 2006). Earlier studies (Ahern et al, 1993; Xanthos et al., 
1998) report that original job descriptions did not reflect a number of duties carried out by the 
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CTNs. At this time, CTNs were not included in the planning stages of the clinical protocol 
and principal investigators failed to include some of their job description in the clinical 
protocol. It should be noted that these issues persisted over time, as indicated by articles, 
systemic reviews and research studies conducted over time. Recent studies investigating the 
role of CTNs in Australia by Wilkes and colleagues (2012) also report similar dissatisfaction 
by CTNs in regards to their job description and job satisfaction.  
2.5.2 Clinical Trials Nurse Responsibilities 
The review of the literature shows the broad categories of responsibilities that CTNs are 
involved in as depicted in Table 2.5. The table shows that CTNs are involved in three 
different aspects of their job which involve patients, study investigators and sponsors. Within 
each of these aspects there is a further breakdown of responsibilities. Generally, the CTN role 
was described as screening and enrolling patients, managing regulatory documents such as 
ethics submissions, data management and liaison with a variety of professionals including 
trial sponsors and maintaining the trial protocol as will be discussed in this section (Nagel et 
al., 2010; Catania et al., 2008; Rickard et al., 2006; Rico-Vilademoros et al., 2004; Loh et al., 
2002; Mueller 2001; Xanthos et al., 1998; Ahern et al., 1993). 
 
An earlier study found that the tasks and activities of nurses involved in European oncology 
trials were mainly related to patient care, and nurses were rarely involved in protocol 
preparation and review (Arrigo et al., 1994). Ahern and colleagues (1993) in their study 
conducted in North America discovered that the trial coordinators for a diabetes study were 
primarily responsible for recruitment, screening, adherence to protocol, medical management, 
education and training and administration (Ahern et al., 1993). The researchers further 
reported that although trial coordinators were responsible for all the above activities, the 
principal investigators did not anticipate such a wide variety of duties especially those 
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relating to medical management and administration duties. This probably reflects the fact that 
nurses in CTN positions absorbed these duties as part of their professional role. Although 
conducted in 1993, this study h had already identified the need to develop a means to define 
characteristics, background, and training appropriate for the CTN position – definitions 
which are still lacking today. 
 
A later Spanish study grouped CTNs’ roles into five categories: administration, clinical 
monitoring, data management, statistics and research-related activities (Rico-Villademoros et 
al., 2004). These categories are similar to those identified by Ahern et al., (1993).  Rico- 
Villademoros and colleagues (2004) reported that most of the CTNs’ time in their study was 
spent on the monitoring activity which included patient registration, recruitment follow up, 
collaboration with clinical research associates, attending audits and reporting serious adverse 
events. This is similar to the division of roles reported by the findings of this literature review 
and outlined in Table 2.5 (Johnson and Stevenson 2010; Thomas 2003; Waller 2003; Haynes 
and Dada 2002; Mueller 2001; Ocker and Pawlik Plank 2000; McEvoy et al., 1991; Hodges 
et al., 1990; White-Hershey and Nevidjon 1990; Willems 1990). 
 
Another study conducted recently within a paediatric oncology setting in the US reported 
subject recruitment, obtaining informed consent, data management and performance of the 
professional nursing role as the main role components of CTNs (Nagel et al., 2010). The 
survey design used for this study was able to capture and measure important nurse-orientated 
inputs such as in depth knowledge and cognition, critical thinking and decision making skills 
used in clinical trials research (Nagel et al., 2010). 
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Advocacy is another role component discussed widely in the literature reviewed. Davis and 
colleagues (2002) conducted a focus group to ascertain the role of study coordinators with 45 
participants, of which 31 were nurses working as CTNs. The researchers identified three 
fundamental roles that pertained to the role of CTNs: subject advocacy, study advocacy and 
patient advocacy. Subject advocacy was the protection of individuals; study advocacy was 
related to gathering good quality data and advancing the goals of the research. Patient 
advocacy was reported as the main responsibility of the CTNs and relates to protecting the 
welfare of the patient throughout the study. The study also identified 19 general skills and 25 
subcategories that CRNs perform. The skills and subcategories are similar to that of other 
studies reviewed here. Bell (2009) discussed the role of patient advocacy as being part of a 
broader nursing responsibility, and that acting as both study and patient advocate, CTNs are 
in a unique position to promote patients’ rights and oversee the ethical conduct of trials. This 
unique positioning of the CTN is echoed by other authors (Fisher, 2006; Davis et al., 2002; 
Yin 2008). 
 
A CTN is often responsible for is screening, recruiting and enrolling patients into trials 
(Nagel et al., 2010; Johnson and Stevenson 2010; Hill and MacArthur 2006; Rickard et al., 
2006; Bell 2009). CTNs identified this role as important because it involved information 
transfer to patients within the informed consent process and ensured patients’ successful 
participation in trials (Nagel et al., 2010; Cantini and Ells, 2007; Stephens-Lloyd, 2004; 
Wright et al., 2002; Loh et al., 2002). The nurses’ clinical knowledge in regards to patient 
procedures involved in clinical trials can assist with ethical submission and patient queries 
(Stephens-Lloyd, 2004).  
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It appears from the literature that CTNs play a role in recruiting patients which relies on a 
responsibility towards the governance and ethics of clinical trials research and maintaining 
the safety of patients/participants. The term advocacy is used frequently in the literature when 
discussing the role of the clinical trials coordinator in the informed consent process. 
However, it should be noted that the authors suggesting the term advocacy from the review 
are nurses themselves. The literature suggests that the role of the CTN is complex and 
multifaceted, involves patient and data management, the informed consent process as well as 
implementation of the study protocol and is seen by investigators as essential to the conduct 
of clinical trials research and the maintenance of GCP.  
2.5.3 Educational Qualifications 
This review of literature suggests that CTNs commence their roles with varied educational 
backgrounds and sometimes little knowledge or research experience is required prior to 
applying for these positions (Johnson and Stevenson 2010; Deave, 2005; Raja Jones 2002; 
Arrigo et al., 1994). A six month retrospective search and  analysis of job advertisements 
placed under the research section of the Nursing Times in the UK demonstrated that there 
were little or no research requirements for research nurses’ posts suggesting, no primary 
degree (eg Bachelor of Nursing) was required to apply for these positions (Deave, 2005). The 
study was investigating if any research knowledge and what type of qualification was 
required to qualify for CTN position. Other studies report that a majority of their respondents 
hold a minimum qualification of an undergraduate nursing degree up to PhD but not really 
provide a critical discussion in regards educational needs and CTN role development (Wilkes 
et al., 2012; Nagel et al., 2010; Rickard et al., 2006; Rico-Villademoros et al., 2004; Davis et 
al., 2002). Raybuck (1997) suggested that CTNs with Masters’ Degree would bring combined 
research skills and advanced clinical expertise to the research settings and further stated that 
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all nurses in the role of clinical trials research coordination and management should pursue a 
research postgraduate to enhance their position as a CTN. 
 
In summary, an assessment of the literature indicates that, while there is no consistent 
requirement for CTNs to have research experience prior to working as a CTN, most will have 
at least a bachelor degree, and some will have postgraduate research or clinical qualifications. 
However even basic qualifications vary between countries of practice, whereby a Diploma of 
Nursing constitutes registration for work as a Registered Nurse in some, while in other 
countries, a Bachelor of Nursing is a minimum requirement for practicing as a Registered 
Nurse. Therefore, almost all nurses transitioning into this role will have nursing expertise and 
professional practice which they will utilise in their role as CTNs. 
2.6 Professional Issues 
In the course of reviewing the literature, two professional issues related to the CTN role 
emerged: conflicts within the role and job dissatisfaction. These issues will be the focus of 
this section. 
The previous section described how CTNs have a wide but poorly defined role within clinical 
trials research. The data and study management aspects of the role necessitate delivery of 
care and treatment in a complex and isolated context while demanding awareness and 
implementation of ethical and professional responsibilities (Cantini and Ells 2007; Hill and 
MacArthur 2006; Davis et al., 2002). Thus, fundamental to the role of CTN is the ability to 
balance patients’ rights with the need to meet recruitment targets and to conduct good quality 
research at the same time (Fisher 2006; Hill and MacArthur, 2006).  
 
The ICH guidelines which guide the conduct of clinical trials globally require that personnel 
working in clinical trials ensure ethical and safe conduct of clinical trials research. The 
42 
 
responsibility of overseeing clinical trials research staff falls upon the lead investigator which 
by type of clinical trials is often a medical practitioner. As these guidelines are taken as 
gospel by sponsors, it sets the tone for management, personnel and clinical research setting. 
Nurses, being a large part of clinical workforce have transitioned in the role of CTN, utilise 
their professional nursing skills and knowledge to ensure optimum outcomes of clinical trials.  
However, are not identified as being an integral component in the conduct of clinical trials 
research within ICH guidelines but instead delegated with other personnel such as data 
collectors and data managers (www.ich.org.au). This is where one of the many challenges 
faced by CTNs arises which is professional identity and role recognition. 
 
Some authors described the ethical challenges that CTNs face, especially in understanding 
that conducting clinical trials research is different yet similar to their professional nursing 
role (Davis et al., 2002; Fisher 2006; Mueller 2001; Mueller and Mamo 2002).  Fisher (2006) 
argued that CTN’s construction of ethical practices (nursing ethics) is generated from their 
interaction with the patients and not from the requirements of institutional review boards or 
ethical principles related to research protocols, thus potentially contributing to conflict. 
 
In the study conducted by Cantini and Ells (2007) in Canada, it is revealed that CTNs have a 
central position in trials, with complex relationships and much potential for conflict with 
other members of the research team. These authors reported that more than half of the 
respondents experienced conflict between their obligations to the participants and their duty 
to ensure successful completion of the study. The most common cause of the conflict was 
with the principal investigator who was also their employer (Cantini and Ells, 2007). 
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The common themes to emerge from these studies are the tension between the two roles of 
being a nurse and a trial coordinator, due to the overlap of roles and responsibilities and 
uncertainty. In addition, this tension is often not recognised by clinical specialist themselves 
(Ocker and Pawlik Plank 2000; Raja-Jones 2002; Stephens-Lloyd 2004). One author argues 
that CTNs are well placed to be future nurse consultants as these nurses are already equipped 
with a sound base for ethical, valid, high quality research techniques as well as excellent 
clinical skills which would facilitate a wide range of nurse-led health services research 
(Stephens-Lloyd 2004).  
 
It can be concluded that the CTN role is complex and requires the nurse to achieve a balance 
between the complex requirements of the clinical trial and a professional nursing role. There 
is no literature discussing the conflict experienced by nurses in this role from an Australian 
perspective. 
 
This review of the literature shows that there is more interest in wanting to quantify the work 
that CTNs do in order to better understand their role and provide more empirical evidence to 
justify and monitor role development. Recent studies assessing job satisfaction have reported 
that overall CTNs are satisfied with their positions but some CTNs report dissatisfaction in 
terms of recognition of work and stress related to increasing workload (Roberts et al 2011, 
Rickard et al., 2007; Nagel et al., 2010). This could apply to many nursing roles however.  
 
Lack of recognition is a common theme in several studies and appears to be a primary source 
of dissatisfaction for CTNs. Davis et al., (2002) note that clinical trial nurses perform much 
of the work in clinical trials but remain unrecognised because principal investigators often 
receive the acknowledgements. Similarly, a survey of research coordinators (Rickard et al., 
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2007) found that the main sources of dissatisfaction for research coordinators were 
remuneration and recognition; compensation for weekend work; salary packaging; career 
advancement opportunities and the availability of childcare facilities. However, coordinators 
were more satisfied with the structural aspects of their position, such as working business 
hours; flexible working hours and high levels of responsibility and control over their work. 
More recently, Wilkes and colleagues (2012) and Roberts and colleagues (2011) found that 
the work environment and lack of support and recognition for work undertaken by CTNs 
remained sources of dissatisfaction. Lack of recognition is also reported in the study by Hill 
and MacArthur (2006); one issue relating to this was CTNs reported feeling isolated because 
of the complexity of their role, leading to lack of understanding from clinically based nurses 
and other health professionals. Other issues which contribute to a sense of professional 
isolation include poor systems for job and performance appraisals, lack of understanding 
from nursing managers and little or no contact with other nursing colleagues (Wilkes et al., 
2012; Roberts et al., 2011; Hill and MacArthur 2006; Rickard et al., 2006). 
 
In conclusion the lack of acknowledgment of the role of CTNs as well as conflict between 
trial-related responsibilities and professional nursing responsibilities emerge as important 
professional issues. Furthermore, the absence of acknowledgment and recognition is cited as 
a cause of job dissatisfaction, underscoring the importance of addressing this issue in the 
future.   
 
2.7 Career Pathway 
The previous sections have discussed how a structured career pathway for CTNs is not 
apparent given the lack of job descriptions, numerous job titles and lack of recognition by 
colleagues. Literature based on both empirical evidence and expert opinion identified lack of 
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a career structure as a major professional issue experienced by CTNs. In addition to reporting 
lack of definition around job descriptions and titles, CTNs have also reported a lack of 
professional support, salary variation and limited specific educational and training support 
(Hill and MacArthur 2006; Rickard et al., 2006; Spilsbury et al., 2008; Stephens-Lloyd 2001; 
Thomas et al., 2008; Yin 2008).  Research coordinators working in clinical trials within an 
intensive care unit reported being dissatisfied with the lack of training opportunities and 
perceived a limited career path (Rickard et al., 2006). Spilsbury et al., (2008) conducted a 
qualitative focus group study and also found that the clinical trial nurses reported a lack of 
confidence in their roles and noted the need for training and support to meet the various 
demands of the role. Based on the studies in this review, the latter point appears to be a key 
issue. 
 
There is widespread recognition that the education and training of clinical trial nurses are 
insufficient and varied (Wilkes et al., 2012; Hill and MacArthur 2006; Mori et al., 2007; 
Rickard et al., 2006; Thomas et al., 2008; Yin 2008). As noted previously, CTNs are required 
to have a basic diploma or degree level nursing training in order to be registered as a nurse. 
Some will have postgraduate qualifications in a clinical specialty but very few will have 
postgraduate qualifications in research or previous research experience (Stephen-Lloyd 
2004). As a result, there is an extensive ‘on the job’ training that clinical trial nurses undergo, 
often in the context of good clinical research practice. In Australia, this has been provided by 
the commercial sector for example, by companies such as Datapharma and Caledonian 
Training. These findings reinforce the need to develop formal educational programs to assist 
CTNs in their role. Thomas and colleagues (2004) suggest that pharmaceutical industry 
groups work with academic establishments to provide CTNs with efficient learning programs. 
It appears as that some progress has been made toward this suggestion.  
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In Australia, some universities now have programs that are tailored to the needs of clinical 
trial nurses working in clinical trials research, for example, the Master of Clinical Trials 
Research Practice that is now offered at the University of Sydney through Sydney School of 
Nursing.  The University of Melbourne now offers the Specialist Certificate in Clinical 
Research (Clinical Trials Research Coordination) in conjunction with the Association of 
Regulatory and Clinical Scientists (ARCS). This program h is aimed at all research staff, not 
only nurses. The Society for Clinical Research Associates (SOCRA) in the United States 
offers certification and credentialing processes for members of all health professions from all 
over the world working in clinical trials research (http://www.socra.org/html/certific.htm). 
Furthermore, establishing an organisation dedicated to supporting the educational and 
professional needs of CTNs has been suggested (Yin 2008; Mori et al., 2007). This would 
enable CTNs to meet socially, discuss and debate professional issues and create policies and 
a framework for their profession which will promote consistency in education, adherence to 
standards and professionalism.  
 
An issue to consider when discussing educational preparation is how similar the CTN role is 
to an advanced nursing practice role (Bird and Kirshbaum 2005, Raja Jones 2002, Ocker and 
Pawlik Plank 2000). It has been argued that nurses working in the CTN role should be 
advanced practice nurses with a Masters’ degree (Raybuck, 1997). For example, CTN skills 
and activities include working as an educator, clinician, researcher and consultant; these skills 
and activities are the same as those of a clinical nurse specialist (Raja-Jones, 2002). It was 
concluded by Bird and Kirshbaum (2005) that there is scope within the role of the clinical 
trial nurse to practice at an advanced level of nursing practice.  Their analysis of published 
frameworks of advancing practice in nursing to explore the role of the clinical trials nurse in 
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oncology led to the conclusion that advanced practice is not defined by the role but by the 
level of skill to which it is performed.  
 
This review has identified the complexity and diversity of the CTN role as well as the 
pressing problem of lack of recognition for this role and the lack of a defined career structure. 
Agreement on a formalised title, position description and the establishment of a clear 
pathway from novice to experienced CTN (Rickard et al 2006) can help address these issues. 
However, further research is needed given the relative paucity of published research in this 
field.  
2.8 Conclusion 
The findings of this literature review suggest that the role of CTN has evolved from one of 
simply collecting data and being a research assistant to now being an integral member of a 
clinical trials research team. The review has reported on how the role of CTN has developed 
to include and integrate organisational, clinical and ethical responsibilities. As well as this, 
CTNs have been described to have and implement the knowledge and the skills required in 
supporting and monitoring both the integrity of studies and the safety of patients.  Further 
findings of the review, state that CTNs are responsible, in many instances, for the co-
ordination of the trials on one or more sites. This involves protocol development, ethic 
approval applications, recruitment and consenting of participants in trials, to administrating 
or assisting with treatments within the bounds of nursing practice code and evaluation of 
protocols. 
 
In light of the complexities of the CTN role, there is a need for greater clarity of this role 
within nursing and research. There is no in-depth discussion into why nursing as a profession 
is crucial to the CTN role and what, if any, contribution CTNs make to the outcomes of 
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clinical trials research and also nursing research. Furthermore, inconsistent educational 
preparation and requirements for CTNs already in the position present a challenge. The lack 
of formal, structured courses is also a challenge for those nurses with an interest in becoming 
CTNs. The lack of a standard job description compounds the problem of establishing a career 
pathway for CTNs. As well as this, there seems to be a lack of collegial and social support for 
nurses working in this role.  
 
This literature review has identified the need to start at the very beginning, with an in-depth 
exploration of the role of nurses working as CTNs. The aim of this study is therefore to 
identify the role of nurses working in clinical trials research by exploring the meaning and 
experiences of being a CTN from the perspective of both CTNs and PIs. Such an analysis 
aims to develop an understanding of the role that registered nurses play in clinical trials 
research with a view to making recommendations for their education and development of 
career pathways. 
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Chapter 3:  Research Design 
3.0 Introduction 
This chapter provides a detailed description of the research design for this thesis. The first 
section of this chapter articulates the research design and its philosophical underpinnings. 
Specifically, it explains the choice of Gadamer’s hermeneutics to inform the study and gives a 
brief history of philosophical hermeneutics before discussing the background to the formation of 
Gadamer’s thinking and the important concepts of philosophical hermeneutics. The second 
section outlines the research process under the following sub-headings: ethical 
considerations, participant selection, data collection and analysis, and how rigour was 
achieved and observed in the study. 
 
Methodology can be the strategy, plan of action, design or process lying behind the choice 
and use of particular methods, thus linking the choice and use of methods to the desired 
outcome (Crotty, 1996). Method is the technique or procedure used to gather and analyse data 
related to the research question (Crotty, 1996). It is important that the right methodology and 
method is chosen to answer the research question because it leads to better outcomes for the 
research and its contribution to the field of inquiry. 
 
In selecting the research design to examine the role of the CTN, a number of factors were 
taken into consideration to describe, explore and examine CTN roles. It was concluded that 
this could be best achieved through interviews that would produce rich data where the CTNs’ 
subjective experiences and perceptions and their thoughts and feelings would be obtained and 
analysed. The limited published research available at the outset of this study and the 
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expansion and evolving role of the CTN in the Australian context highlighted the potential 
benefits of using a qualitative research design. The underlying principles of qualitative 
research emphasise the need to both describe and understand people and provide insights into 
how people make sense of their experiences when researchers have little knowledge about the 
area of investigation (Rice and Ezzy, 1999).  
 
Qualitative research inquiry seeks to explore and interpret the phenomenon under 
investigation through either critical or interpretive approaches (Schneider, 2007). Critical 
approaches seek to enable empowerment, emancipation and equality for research participants 
and to change or challenge existing social structures, for example action research or feminist 
research (Schneider, 2007). On the other hand, interpretive approaches focus on 
understanding the meaning of human experiences and actions, for example phenomenology, 
grounded theory and hermeneutics (Crotty, 1996).Therefore to gain an understanding of the 
role that registered nurse play in clinical trials research, an interpretive approach was chosen. 
Furthermore, a hermeneutic approach, based on Gadamer's philosophy regarding the pre-
requisites of understanding and existential interpretations is applied because, based on a 
hermeneutic perspective, the data that are compiled is dependent upon interpretation and any 
relevant insight or understanding stemming from the researcher’s background.  
 
3.1 Hermeneutics Philosophy 
The word hermeneutics is derived from the Greek word ‘hermeneueuein’, literally meaning 
‘to interpret’ and from the noun, ‘hermeneia’ to mean ‘interpretation’ (Thompson, 1990). 
Hermeneutics was originally a set of techniques for interpreting written texts and was initially 
developed to translate biblical texts (Thompson 1990; Packer 1985).  
 
51 
 
The long history of hermeneutics can be traced back to St Augustine who used this as a 
method in interpretation of the Holy Scripture (Abulad, 2007). Friedrich Schleiermacher 
(1768-1834), who played a founding role in developing modern hermeneutics, introduced the 
concept of the language, stating that no understanding can take place if one does not think 
(implying the thinker) and one cannot think if there are no words (implying language) 
(Abulad, 2007). Schleiermacher highlighted that language is central to our understanding as 
everything is encased within the language that we speak, whether it is written or spoken, thus 
introducing the concept that hermeneutics could be applied with any text. 
 
William Dilthey (1833-1911) further contributed to Schleiermacher’s work by arguing that 
human beings come to understand their world through reflection and interpretation with other 
human beings, and they do this over time, bringing their traditions, history and language to 
their reality (Chadderton, 1997). Further to this idea, Dilthey considered a methodology, 
arising from Schleiermacher’s interpretive inquiry, where each part is considered in relation 
to the whole and vice versa, thereby establishing the hermeneutic circle (Chadderton, 1997). 
The turn towards philosophical hermeneutics was influenced by the work of Martin 
Heidegger and later expanded by his student Hans-Georg Gadamer (1900-2002) who is 
credited with philosophical hermeneutics. It is this approach that has been selected for this 
study. 
 
3.2 Gadamer’s Philosophical Hermeneutics 
Gadamer’s work has been recognised as being central to the evolution of contemporary 
hermeneutic philosophy. Contemporary hermeneutics emphasises the human experiences of 
understanding and interpretation (Thompson, 1990). Gadamer describes the path to 
philosophical hermeneutics in his book Truth and Method. Gadamer (1989) posed the 
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question ‘How is understanding possible?’ emphasising the meaning of being through 
understanding as a philosophical question. He argued that there is no such thing as a method 
to describe understanding because method implies a scientific approach rather than an 
interpretive approach (Gadamer, 1975). Gadamer (1989) expanded on the work of both 
phenomenology and hermeneutics by Heidegger by offering an interpretive approach to 
understanding. Gadamer emphasised understanding, stating that it is situated in our historical, 
dialectical and linguistic tradition. Gadamer’s exploration of dialogue and conversation as a 
mode of understanding is central to the study of hermeneutics and in the conduct of 
interpretive inquiry which informs this research study. 
 
Gadamer’s hermeneutics as outlined in his cornerstone work Truth and Method (Wahrheit 
und Methode, 1989) focuses on the linguistic nature of understanding. His hermeneutics 
philosophy examines the nature of understanding where he states that no particular technique 
or procedure of inquiry guides a researcher to understanding. Gadamerian hermeneutics 
concentrates on expanding horizons of understanding through dialogue, between people or 
between a researcher and texts. In a research context, the researcher engages with the text 
(written or verbal data) to make sense out of it and therefore develops an understanding to 
and for the text. In engaging with the text, the researcher brings to the process his or her 
background, knowledge and experience, in essence who the researcher is; Gadamer refers to 
this as tradition. 
 
According to Gadamer (1989), tradition is not something that can be consciously evaluated. 
Binding and Tapp (2008 p 123) describe tradition as ‘cultural, social, and discursive features 
of our everyday worlds‟. Tradition is what we bring into a conversation or when we are 
reading a text. It is part of us; we project our thinking from within our tradition, which also 
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includes our pre understandings that we bring to any event of understanding. It is these pre 
understandings that inform the questions we ask and to a certain extent what we accept as 
answers.  
 
Therefore understanding stems from what we have learnt through our professional and 
personal history, what we are born into and what we learn as we live, through our use of 
language in textual and conversational settings. This means that the researcher is not 
completely unaware of the world of the participant. In order to ask the research question, the 
researcher should already have some understanding of what is sought; hence we have pre 
understandings or fore-structures of understanding (Geanellos, 1998; Walsh, 1996). Gadamer 
(1989) argues that it is important to identify the pre understandings and acknowledge them so 
that they can be taken into account in the act of understanding. An act of understanding 
occurs when the researcher enters into conversation with participants or reads texts of 
interviews because the researcher joins in a dialogue with them. This process occurs in a 
circular motion where the researcher goes from whole to part of conversation, or text and 
back, to make sense of the whole conversation or text through a cyclic process known as the 
hermeneutic circle (Debesay, Naden, and Slettebo, 2008). 
 
The hermeneutic circle refers to the idea that an understanding of the text as a whole is 
established by reference to the individual parts and an understanding of each individual part 
by reference to the whole. Neither the whole text nor any individual part can be understood 
without reference to one another, therefore establishing it as a circle. Gadamer (1989) further 
contributed to the hermeneutic circle by stressing that the meaning of a text must be found 
within its cultural, historical, and literary context, stating that, within the hermeneutic circle, 
each person comes to an encounter with pre understandings. As the conversation progresses, 
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the pre understandings that we begin with are replaced with pre understandings that take into 
consideration the information we have received, and the meanings that have emerged. In the 
hermeneutic circle, one does not remain at the same place but moves continually as new 
knowledge is acquired. As this process occurs continually, the researcher needs to be open to 
the meaning of the text or the other person and questioning one’s own interpretation so as to 
be open to new interpretations. Gadamer (1989) refers to this as a fusion of horizons. 
 
Gadamer (1989) defines horizons as „the range of vision that includes everything that can be 
seen from a particular vantage point‟ (p.302) which shifts with new understanding.  Fusion 
of horizons is about being open to different standpoints, consequently allowing the 
standpoints to influence and speak to the researcher or the reader. It does not however mean 
that the researcher abandons his or her horizon and steps into the horizon of the research 
participants, rather it is about the researcher placing his or her pre understandings derived 
from the history of the researcher alongside that of the research participants to illuminate 
what the participants are trying to say.  
 
A notion of fusion of horizons will be to ‘deliberately let into our ontology an awareness of 
something unexpected… unfamiliar…and to be consciously aware of that differentness.’ 
(Phillips 2007 p. 91). Hence, the researcher is encouraged to think beyond his or her 
understanding, allowing for openness that there may be other possible meanings of what the 
research participants are trying to convey, creating a new horizon in the process whereby 
understanding is generated. In keeping with this view of openness, the process of 
interpretation occurs within a circle that is defined by our horizons of understanding. 
 
55 
 
Hermeneutics describes this process by which insights into human behaviour and our world 
are interpreted and communicated to the rest of the world. This study aims to follow the 
tenets of Gadamer’s hermeneutics because interpretation within the framework of CTNs 
seeks to manifest textual meanings rather than individual ones. In engaging within the 
hermeneutic circle, addressing pre understandings and reflecting their origins and the 
adequacy and legitimacy of them, allows the researcher to interpret the true meanings of what 
the participants are saying.  
3.3 Study Design 
This section outlines the methods used in the study. The selection of the study setting, study 
participants, ethical considerations, data collection and analysis are discussed and an outline 
of the criteria by which this work can be judged as rigorous is also presented. 
3.3.1 Study Setting 
This study was undertaken in the clinical trial centres of two large public teaching hospitals 
located in metropolitan areas in New South Wales. Three public hospitals were initially 
approached but the third hospital was not included in the final study because their ethics 
approval process took longer than expected and sufficient participants were recruited at the 
other sites to achieve data saturation before ethics approval at the third site was granted. 
Within the two public hospitals, five different clinical specialties were approached. The study 
settings were selected based on several factors such as the types and phases of clinical trials 
conducted at each site, the reputation of each of the study settings and their accessibility to 
the researcher. 
 
The first factor in site selection was the range of common types of clinical trials research 
conducted in each setting.  For example, both sites conduct treatment trials that test new 
combinations of drugs or new approaches to surgery; prevention trials that look for better 
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ways to prevent diseases; or diagnostic trials that are conducted to find better tests for a 
particular condition. It was also important to seek study settings in which a range of phases of 
pharmaceutical drug trials were conducted. This was an important factor when selecting the 
study settings because it indicated that the pool of study participants had a range of clinical 
trials experience. The study settings chosen for the research study were conducting all three 
types of clinical trials research as well as various phases (Phase I – IV) drug trials. 
 
The second factor in selecting a site for this study was the reputation of each study setting as 
a clinical trials centre. This is as an indicator of the quality of clinical trials research 
conducted at the centre and the calibre of clinical trials personnel involved. A highly regarded 
clinical trials centre would seek to conduct clinical trials that were reputable, also employing 
CTNs that were trained and practiced according to good clinical practice (GCP) standards. 
 
The third factor was the accessibility of the study settings. Factors taken into account were 
facilities that were available for interviews and heads of departments who were willing and 
interested in facilitating research. In order for the study to proceed smoothly and to gain as 
much information from the participants as possible, the surroundings have to be comfortable 
and familiar, and provide adequate privacy to the participants (Minichiello, 1995). 
 
The support and interest of heads of departments was important as they were key facilitators 
in encouraging and motivating their staff members to participate in the research study and 
their permission to conduct the study was required. The heads of departments approached 
were very supportive of the research study and went to great lengths to ensure that 
appropriate rooms were available for interviews and ensure that clinical trials nurses and 
principal investigators were informed of the study through weekly departmental meetings. 
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3.3.2 Study participants 
Study participants were recruited from the clinical trial centres of two large public teaching 
hospitals located in metropolitan areas in New South Wales. These were registered nurses 
working in the management of clinical trials, and medical practitioners involved in clinical 
trials as principal investigators. The selection of study participants was purposive as the 
research study is investigating nurses working in the role of clinical trials research. Therefore 
nurses working in the role of CTN were approached to participate in the study. Medical 
practitioners were included in this purposive sample as they worked closely with CTNs and 
would be able to shed light on the CTN role. 
 
The inclusion criteria for clinical trials nurses (CTNs) recruited to the study were that the 
participant should be a registered nurse, and working in clinical trials for a minimum period 
of a year. The inclusion criteria for principal investigators (PIs) included being licensed 
medical practitioners, working in clinical trials for a minimum of a year and as a principal 
investigator of at least one clinical trial. The decision to include participants with a minimum 
of a year’s experience was to ensure that they had a sound knowledge of working in clinical 
trials research. 
3.3.3 Recruiting Participants 
Recruitment of participants commenced as soon as ethics approval was received from the 
institutions at which the research and interviews would be conducted. Two strategies were 
deployed for recruiting participants. One strategy involved recruitment through fliers and 
advertisements and the second strategy was approaching heads of departments. Fliers were 
placed in strategic locations such as department notice boards and advertised contact details 
for the researcher. Two participants (one medical practitioner and one CTN) were recruited 
using this strategy.  
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Heads of Departments facilitated access for the recruitment of clinical trials personnel by 
allowing the researcher to present the research study at weekly clinical meetings the heads of 
departments also assisted in identifying potential participants who were then approached by 
the researcher and given information about the study. More than 60 % of the study 
participants were recruited through these clinical meetings, especially the medical 
practitioners. 
 
Another avenue for recruitment was through word of mouth, as medical practitioners and 
nurses were made aware of the study by colleagues. Two of the CTNs were recruited through 
word of mouth. After speaking with potential participants independently, and assessing their 
suitability according to the study inclusion and exclusion criteria and gaining verbal consent, 
individual interviews were organised. This method of recruiting is often referred to as 
snowballing where potential participants are identified by other participants who share the 
research characteristics (Schneider, 2007). It is also used when the population under study is 
difficult to gain access to as it was in this research study. 
 
In total, 19 CTNs and 12 PIs were approached, with 10 in each group consented. Some of the 
reasons for not participating in the study related to time commitments, not being available 
during the period of the study, a negative influence from one PI affecting CTNs’ decision not 
to participate in the study and general disinterest in the research. In conducting initial data 
analysis with the first few interviews, it was noted that interviews could be stopped once 
there was no further significant data were generated. This is also known as data saturation, 
where no new or relevant data emerge from the interviews (Schneider, 2007). Therefore 
recruitment was ended with ten participants in each group when data saturation was achieved.  
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The ten CTNs consenting to participate in the study were recruited from the specialty areas of 
Respiratory, Haematology, Hepatology, Neurology and Oncology clinical trials research. 
These CTNs had worked at an advanced level of nursing for a substantive period of time 
before transitioning to clinical trials research (Table 3.1).  All of the CTNs held postgraduate 
qualifications in their clinical speciality which ranged from a Graduate Certificate to 
Graduate Diploma. Eight of the CTNs had held senior nursing roles, before transitioning to 
clinical trials, two of the CTNs had experience in educating undergraduate nurses within the 
tertiary education setting and one of the CTNs held a Master in Business Administration. 
Eight of the CTNs interviewed were responsible in their clinical trial role for one other staff 
who was working with them. At the time of the interview, all the CTNs had attended courses 
in Good Clinical Practice and were current with their nursing registration. 
Table 3.1: Clinical Trial Nurse Experience 
 
CTN 
(Pseudonym) 
Clinical Nursing Experience 
(Years) 
Clinical Trials Nursing 
Experience 
(Years) 
Lara 7 9 
Mel 13 5 
Rina 19 7 
Sherry 16 5 
Bal 10 2 
Ann 14 1.2 
Kate 15 5 
Sue 20 10 
Vicky 6 5 
Cris 12 8 
 
The ten medical practitioners consenting to take part in the study were all consultants from 
the following therapeutic areas: Respiratory, Haematology, Cardiology and Oncology. Five 
of the principal investigators were professors and held academic positions in universities 
across New South Wales at the time of the interview, therefore they were not only involved 
in research at a hospital level but were also recognised national and international leaders in 
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their area. Three of the medical practitioners were heads of departments at the time of the 
interview and were involved in decisions about the employment of CTNs. Each of the 
medical practitioners had been involved in clinical trials for a minimum of two years (Table 
3.2). 
 
 
 
Table 3.2: Principal Investigators’ Clinical Trial Experience  
 
PI 
(Pseudonym) 
Clinical Trials Experience 
(Years) 
Rob 30 
John 20 
Megan 3 
Jane 4 
Jack 10 
Ryan 11 
Roger 6 
Roy 10 
David 20 
Sam 11 
 
3.3.4 Data collection 
Data collection commenced by face-to-face individual interviews as soon as participants 
provided their consent for the research study. Utilising interviews enables researchers to gain 
a deeper knowledge of the phenomenon under investigation compared to other methods, such 
as surveys as they involve social and interpersonal interaction with participants (Gubrium and 
Holstein, 2001). Semi-structured interviews allow for the broad concept of the study to be 
guided by the interviewer and be facilitated by devising an interview guide (Polit and Beck, 
2006; Minichiello et al. 1999). Semi structured interviews are widely used to seek reliable, 
comparable data. This style of interview enabled the researcher to ask a mix of open and 
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closed ended questions and to manage the interview with questions prepared ahead of time. 
Semi structured interviews also allow persons being interviewed the freedom to express their 
views in their own terms.   
 
An interview guide was developed to assist as an aide-memoire, to ensure that the key points 
of the study were covered and to provide clarity. The interview guide was reviewed several 
times prior to each interview in order to become familiar with the questions and the content 
that needed to be covered during the interview. Questions focused on the participants' 
professional backgrounds, transitions to clinical trials research, roles in clinical trials and 
views of the future direction of clinical trials nurses. The final version of the interview guide 
is included as Appendix A. 
 
Data collection followed a schedule that was observed closely to ensure that all participants 
were interviewed within the planned time frame for completion of the research study. Two 
interviews were scheduled per week and were conducted in one clinical speciality before 
progressing to the next specialty area. For example, all CTNs and PIs recruited in oncology 
were interviewed prior to proceeding to haematology. This strategy enabled the researcher to 
complete analysis in one area and to create more opportunities for seeking a broader range of 
participants. In short, the researcher was able to use the initial data analysis to shape 
continuing data collection.  
 
Participants preferred to be interviewed in their work settings, and chose the times for their 
interviews to suit their working hours. The selection of the interview venue was important; 
settings chosen by the participants facilitated their ability to relax and open up in the 
interviews. Participants were offered other venues, such as rooms at the university or their 
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homes as alternatives to being interviewed at work. Only one participant asked that the 
interview be held at her home. Interviews were held in conference rooms, in available clinic 
rooms and in the participants’ offices, mostly either early in the morning prior to work, for 
example at eight am, or during the afternoon, at about two pm. 
 
Time played a big factor in conducting the interviews.  All but one of the participants was 
interviewed at work, which necessitated in the average length of an interview being between 
45 minutes and an hour. If the planned scope of the interview was not completed during that 
time, another appointment was made immediately. Also, it was difficult to arrange interview 
times with the medical practitioners, as they were committed to various clinics, teaching and 
surgery. As the interviews in some cases were held a few weeks after the recruitment of 
participants, some had forgotten that they had agreed to participate in the study and to being 
interviewed, and the process of reintroducing the study to them and gaining their consent for 
interviews had to be repeated. 
 
Interviews were all recorded using a readily available analogue audiotape with an omni- 
directional microphone. The microphone was very sensitive and ensured that participants did 
not need to talk loudly for recording, thus creating a more personal and confidential 
environment. Each interview began with questions on the participant’s background and then 
proceeded to how they became involved in clinical trials. The purpose was to allow the 
participant to feel comfortable and to open up to further questioning. Questions on 
background also provided an insight into the participants’ personal journey of how they 
became a CTN or a PI. Following questions focussed on the participants' role in clinical 
trials, permitting them to elaborate on what they did, how they went about their work and if 
there were any issues that arose in association with their role. Issues were discussed as these 
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were raised by the participant, in particular, the participant was encouraged to discuss how 
these issues were being managed and the challenges they faced in their roles as CTNs or PIs. 
Inquiry on what the participants thought the future held for CTNs was another topic raised 
during the interview. Finally, participants were asked if they had any other questions or 
wished to add anything else to the interview data. Participants were also encouraged to 
provide as many examples of real life situations and reflect on their own experiences as this 
added to the richness of the data generated. 
After each interview, the tapes were transcribed within 24 hours onto a word processing 
programme while the information was still fresh in the mind of the researcher.  Reflecting on 
the information gathered during each interview led to modifications to the interview guide as 
needed and discussion of any issues that arose with the research supervisors, prior to 
scheduling the next interviews. Transcribing and reflecting on the interview within 24 hours 
was crucial because, if any problems arose, for example a poor recording or missing data, 
reviewing field notes could assist in resolution or by contacting the participant to organise a 
follow up interview. This occurred during three interviews with CTNs where problems were 
rectified by arranging one follow up interview with each, with no subsequent issues arising. 
However, if such problems had not been addressed quickly, it may have been difficult to 
obtain another appointment as participants were often very busy with work commitments.   
Vital information could have been lost if the problems had been left unresolved.  
3.4 Data Analysis 
Analysis can occur at various stages of data collection in qualitative research. For the purpose 
of this study, an initial analysis of data was conducted to ensure that initially, the appropriate 
cohort of participants was being interviewed and second, that appropriate interview questions 
were being asked to elicit deep and meaningful information from participants. All interview 
audiotapes were transcribed by the researcher, allowing the researcher to work closely with 
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the data and immerse herself in it. Interviews were transcribed verbatim into Microsoft Word, 
with any identifying information removed during transcription. 
 
Data analysis was conducted within the hermeneutic philosophy framework which is directed 
towards finding the meaning from the text. Several steps were taken in order to understand 
the interview text. First, the interview text was read by the researcher several times in order to 
immerse oneself in the text, seeking to achieve a deep familiarity with it, and to acquire a 
sense of the whole. The text was read with the research question in mind so as to gauge 
whether the question was being answered. Secondly, headings relevant to the research study 
were extracted and an interpreted meaning attached to the statement produced. The data were 
then organised into different themes and sub-themes. These were charted on a large spread 
sheet with notes that indicated the locations of quotes in the interview text that provided 
evidence for the emerging themes. As the analysis continued, the themes were regularly 
reviewed and occasionally divided and merged. The final action was to reflect the themes 
back onto the interview text to ensure that the analysis had produced descriptions 
representative of the research question. This to-ing and fro-ing of the analysis was continuous 
and circular in motion, in keeping with a hermeneutic circle.  
3.5 Rigour and Trustworthiness 
It is critical that the rigour of the research method, and its application reflects, the robustness 
and integrity of the research process is established. For this research study, Sandelowski’s 
(1986) description and discussion of the three criteria for evaluating qualitative research 
study are applied: these are credibility, auditability and applicability. 
 
Credibility addresses the issue of ‘fit’ between participants’ views and the researcher’s 
representation of their views (Schwandt 2001). A study achieves credibility when the reader 
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is confronted with recognisable experiences from faithful and close descriptions of 
participants, presented by the researcher. Credibility is confirmed through a number of 
strategies such as member checks, peer debriefing, prolonged engagement, persistent 
observation and audit trails (Lincoln 1995).  The processes used to enhance credibility in this 
research study included the researcher presenting faithful interpretations of the CTNs’ 
experience, which other CTNs would recognise as representative of their own. Immediate 
transcription of the interviews to ensure no loss of information from the interview process 
was undertaken 
The analysis of the data using Gadamer’s hermeneutic approach was the second step in 
ensuring credibility. The key elements of the hermeneutic approach are the hermeneutic 
circle and the fusion of horizons as discussed and described in earlier sections of this chapter. 
  
Analysis of the data using hermeneutic circle, involves an extended period of reflection of 
both, parts and whole of the interview data in order to derive meanings presented. The 
researcher understands that this process of toing and froing must come to an end, and holds to 
an understanding that is presented by the participants at that moment. Simultaneously, the 
researcher uses her horizons, derived from past and current experiences as a CTN to aid the 
process of analysis. The researcher, as described in the first chapter, experience as a clinical 
trials nurse. The researcher’s background as an experienced CTN guided the development of 
the research question and study. The professional background the researcher brought to the 
study provided an informed examination to explore the role of clinical trials nursing as her 
experience contributed to her understanding and description of the participants’ experience 
which is consistent with Gadamer’s hermeneutic philosophy. 
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Although the reader may not share the researcher’s interpretation, they are able to follow the 
researchers’ steps in analysis and the rational for the conclusions reached.  The process of 
interpreting and demonstrating that each step in the data collection and analysis is connected 
to the outcome leads to an audit trail being established. A study’s trustworthiness may be 
established if a reader is able to audit the events, influences and actions of the researcher 
whilst assuring quality in qualitative studies (Ackerman et al., 2006; Koch 2006; Rice and 
Ezzy (2005).  According to Koch (2006), the audit trail concept stems from the idea of 
financial audits where independent auditors authenticate a firm’s accounts and examine them 
for the possibility of error or fraud.  It is this similar concept and idea that can be used in 
qualitative research. According to Sandelowski (1986), a study’s findings are auditable when 
another researcher or reader can clearly follow the decision trail and possibly arrive at the 
same or similar but not conflicting conclusions given the researcher’s data, perspective and 
situation.  
In effect, the audit trail provides evidence that the interview text has gone through a process 
of analysis, reduction and synthesis that can be followed and understood by the reader. This 
process is transparent in this study because detailed accounts of the design planning, 
sampling, data collection methods and analysis decisions are presented. An audit trail also 
helps achieve consistency within the research study. 
 
Applicability refers to the degree to which the findings can be applied to other context and 
settings (Sandelowski, 1986). This research study has been able to establish applicability by 
providing details of the data analysis and the decisions that led to the findings. The study 
findings are situated in the participants’ current situation and the interpretation is of the 
researcher’s fusion of horizon with participants. By understanding data presented in this 
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study situated in its present context, a new researcher can make comparisons and therefore 
transfer these findings to situations and context of their own. 
 
In summary, the findings of this research study reflect implementation of credibility, 
auditability and applicability of the study thus achieving quality and trustworthiness. 
 
3.6 Ethical considerations 
Prior to the commencement of the research, applications to the relevant ethics committees for 
the three sites were made. An ethics application for Research Involving Humans was 
approved by the University of Sydney Human Ethics Committee as well as the Human Ethics 
Committees covering two sites within the Sydney South West Area Health Service 
(SSWAHS) (now the Sydney Local Health Network). 
 
Informed consent was an important principle adhered to in the study. The study was 
explained in full to the participants by the researcher to avoid any confusion on the part of the 
participants and also to provide an opportunity for them to ask any questions relating to the 
study. As stipulated by the ethics committees, every participant was given a Participant 
Information Sheet (Appendix B) which outlined the aims and objectives of the study and 
stated that they were free to withdraw from the study at any time without penalty or prejudice 
to their work. No participants requested to withdraw from the study. Participants were also 
required to sign an individual consent form (Appendix C) which outlined in detail what they 
were agreeing to before the commencement of their interviews. 
 
Participants were made aware that their participation in the research was strictly confidential 
and only the research supervisors and researcher had access to the study information, 
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including recordings and any personal references to participants. Permission was obtained 
from participants for the interviews to be audio taped. All personal details were removed 
from transcribed materials and from other presentations of the interview data. Pseudonyms 
were used to identify the study participants as illustrated in Tables 3.1 and 3.2. As requested 
by the ethics committees, the tapes, journals and all transcripts are stored in a locked facility, 
accessed only by the researcher, and will remain so for a period of seven years. All tapes will 
be wiped clean and transcripts shredded after this time. 
3.7 Conclusion 
This chapter has discussed the methodological underpinnings and the research methods used 
in this research study. The choice of approach was important in ensuring that the research 
question was answered and the research aims achieved. Hermeneutics, in particular 
Gadamerian hermeneutic philosophy was used as an approach to achieve an understanding of 
the role of registered nurses working in clinical trials research in Australia. 
 
Semi structured interviews with open ended questions were used to seek information from 
CTN and PIs who were participants of this study. This form of data collection delivered rich 
and deep data that enabled the researcher to find meaning in the way CTNs and PIs interpret 
the role that registered nurses play in clinical trials research. The study participants came 
from a diverse clinical background with many years of clinical experience between them 
which contributed to the richness of the interview data. Data analysis is described in detail to 
improve the trustworthiness and quality of the study data presented. Two subthemes and one 
overarching theme have emerged from the data analysis and will be described in the next 
chapter. 
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Chapter 4: Understanding the Clinical Trial Nurse 
4.0 Introduction 
This chapter presents the findings to the research question posed in Chapter One: 
‘What is the role of registered nurses in clinical trials research in Australia? 
The discussion explores the aim of this research which was to examine and describe the role 
of clinical trials nurses in research in Australia from the perspective of clinical trials nurses 
themselves and the principal investigators of clinical trials..  
 
Data analysis followed the principles of Gadamerian hermeneutics to facilitate an 
understanding of the role of the clinical trials nurse (CTN). Data were collected through 
individual face to face interviews and analysed to identify themes that describe the reality of 
the role that registered nurses play in the conduct of clinical trials in Australia. The analysis 
followed a process of categorising meanings from the interview texts, which led to the 
emergence of an overarching theme of ‘Being a Nurse’ and two subthemes: Functioning from 
a Professional Nursing Perspective’ and ‘Applying Therapeutic Knowledge and Clinical 
Skills’.  
 
Figure 4.1 illustrates the themes and how they relate to each other: the subthemes are parts of 
the overarching theme and the (whole) overarching theme is made up of (parts) the 
subthemes. The themes are presented as separate components to help understand the whole 
picture of ‘Being a Nurse’. 
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Figure 4.1: Themes from Analysis of Interview Data 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter presents the findings of the hermeneutic qualitative analysis in three parts. The 
first part presents the overarching theme emerging from the data: Being a Nurse. This theme 
outlines how the CTNs view themselves as essentially being a nurse in clinical trials research. 
Both nurses and principal investigators of clinical trials identify that CTNs bring their nursing 
attributes to their role in clinical trials by virtue of their knowledge, skills and nursing 
professional backgrounds. Participants identified that the CTNs primarily function as nurses, 
identify themselves as a nurse, and practice within professional nursing codes of ethics, 
conduct and guidelines while working in a clinical trial setting. This is further described 
when exploring the other two key subthemes in part two and three respectively. The 
overarching theme with its subthemes is supported by exemplars from the interview 
transcripts in the following sections. 
  
Applying 
Therapeutic 
Knowledge 
and Clinical 
Skills 
Functioning 
within a 
Professional 
and Ethical 
Nursing 
Framework 
BEING 
A 
NURSE 
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4.1 Being a nurse 
Analysis of the interview data identified that nurses working in clinical trials positions, 
whether titled ‘nurse’ or ‘coordinator’, look at this role as a nurse working in a clinical 
research environment. This framing of their clinical trials role influenced how they undertook 
many aspects of the research role. It should be noted that the some of the CTNs worked from 
within hospital departments, others conducted clinical trials from a university research unit 
and sometimes visited wards to recruit or to consult with patients and other health care staff. 
The analysis of the interview data indicates that because CTNs view themselves primarily as 
nurses, it influences the way they continue to work in clinical trials research. For example, 
some of the CTNs would describe their day to day activities from within a nursing 
framework. For example Sherry, a clinical trials nurse with 16 years of clinical experience 
described her day to day responsibilities: 
‘...about explaining stuff to the patient in terms that they understood and 
using my background really as a nurse to do the follow up work and support 
as well,...‟ CTN Sherry  
Or the CTNs simply describe themselves as nurses when describing their role as does Rina 
throughout her interview:  
 „...the level to which I as a nurse or an intermediary...‟ CTN Rina 
Some of the CTNs would refer to their clinical speciality and how their decision to apply for 
their current position was influenced by their clinical background, as described by Kate and 
Vicky: 
‘My background is in Oncology, Haematology, 15 years of that and when I felt like a 
change of job and there was a job available in haematology as a clinical trials nurse, 
so I applied and got it.‟ CTN Kate. 
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Of interest, it was also noted that some of the PIs switch between the term nurse and clinical 
trial coordinator, research assistant or clinical trial nurse during the course of the interview. 
Therefore, although the CTNs are employed under the various formal titles, they were still 
referred to as a nurse by the PIs indicating that the PIs viewed the CTNs first and foremost as 
nurses. Furthermore, the PIs referred to nursing attributes that helped trial coordinators in the 
management of clinical trials. Here John, a PI for more than 20 years, indicates how CTNs 
use nursing strategies and values to enhance patient recruitment: 
„...that doctor has a an initial discussion with patient and that is followed by 
the clinical trials nurse, who maintains sort of a personal interest in the 
patient and follows through, and that has been a secret of successful trials 
that we have conducted in this Unit, why our recruitment has been so high.‟ 
PI John. 
 
A need for definition and greater clarity for the role of nurses working in clinical trials 
research was raised during the interviews. The CTNs reported a lack of recognition of the 
role within the wider professional nursing circles, and little collegial support. They suggest a 
national body be established to monitor standards, implement peer review to evaluate their 
practice and that professional courses be initiated and conducted for nurses who are interested 
or already in the clinical trial role. They also suggested that the clinical trials nurse role be 
introduced at an undergraduate level as a valid career pathway for nurses to encourage greater 
numbers of nurses to undertake this role. 
 
Rina, who has worked as a clinical nurse for more than ten years and oversees CTNs in an 
oncology unit, stated passionately that as a group, CTNs need to recognise the role as their 
practice. She explains that if CTNs do not acknowledge and accept their role in clinical trials 
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nursing as part of their nursing practice, thus not defining the role, issues relating to training 
and role recognition will continue to arise: 
‘If you don‟t have training that addresses the practice role then you need to 
know what the practice role is. Well that is not defined.‟ CTN Rina 
Rina described how the role of the CTN is often misunderstood by the wider nursing 
community which gives rise to confusion in regards to titles and between the roles of nurse 
researcher and nurses in clinical trials research.  
‘A lot of nurses reject what CTNs do because they don‟t see it as contributing 
to professional research... unless you start addressing the nurse researcher 
and even just defining the fact that nurse researcher is different within your 
own profession, nothing will change, it will be always be fraught with 
confusion and so that is part of the problem.‟ CTN Rina 
She further maintained that without definition of clinical trials nursing, the role would remain 
one without regulation and would continue to present very little to non-existent support for 
nurses in this role in terms of further education, collegial support and a recognised career 
pathway: 
‘Because the nurses are working in a trial…and doesn‟t have a national body 
that accredits or has any accrediting type role because they are unregulated 
then that means you can‟t address these things in a very easy way in the first 
instance.‟ CTN Rina 
 
Sherry and Lara shared ideas similar to Rina’s and suggested  that a national body be 
established to ensure standards of practice, educational needs and  collegial support for 
clinical trials nurses are supported, for example:  
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‘I‟d like to see clinical trials as a specialty if you like on the New South Wales 
Nurses Board Registration so that it is recognised as a specialty...as part of 
the nursing award, like other roles like clinical nurse consultant wound care 
or diabetes education something like that , so that is what I like to see...larger 
nursing workforce in clinical trials so like to see some career structure within 
that.‟ CTN Lara 
 
To further recognise the role of CTNs and to bring focus to the role as a valid career pathway, 
it was suggested that nurses at grass root levels be made aware of the role as maintained by 
Rina,   
„…once we start addressing CTN as a professional pathway at 
undergraduate level and just flag those options as somewhere you can work.‟ 
CTN Rina 
 
The CTNs also described what they foresee as the future for the role of CTNs. Bal predicts 
that the role is going to get more complex as demands for clinical trials research increases, 
for example she states: 
 „,funding will impact the way trials are run, there will be pressure on CTNs to 
enrol patients and as organizations get bigger and larger there will be more 
demands on the CTN time,...The role will get more technical, more training 
according to that needs to be established and also more complex in terms of 
treatment options‟ CTN Bal 
Cris suggests that the complexities would involve increased responsibilities in data 
management and move towards electronic data capture:, 
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‘Buried under a vast pile of paperwork, where it is going? Look it is all going 
to be shifting to electronic, we have already started ‟CTN Cris 
 
Many of the CTNs referred to the need to enable progress and expansion of baseline 
knowledge and skills in clinical trials research, training in regulatory affairs and gaining 
informed consent, and the need to gain an understanding of the whole clinical trials research 
industry and communication skills. Cris, who has varying levels of experienced CTNs 
reporting to her suggested: 
‘Education, clinical trials, I guess it depends on what their base line 
knowledge level is... they really need to know about an overview of the whole 
process not just their particular study but the whole process of the industry 
needing to look at these questions and the process of getting drugs to the 
market place and the process of getting the ethics committee approval and the 
process of recruiting the patient...‟ CTN Cris 
 
All of the CTNs mentioned some form of training for both novices and experienced CTNs. 
However, a few of the CTNs mentioned the need for a formal postgraduate course to enable a 
career pathway for the role. The courses available at the time of the interviews were mainly 
sponsored by the clinical trials research industry, for example one of the CTNs suggested:  
„...postgraduate course would be a great thing, I think that is where it will 
end up…. I think there needs to be a postgraduate course in it…‟CTN Vicky 
 
The participants were confident that the clinical trials nursing role is here to stay. Participants 
clearly identified a need to establish a national body that will help regulate, provide collegial 
support and grow this role within the wider nursing body. The aspects that the CTN 
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participants have mentioned in regards to continued training and the future consolidation of 
the role apply to functioning as a profession and contributing to their professional role as a 
nurse. 
 
In analysing the data, it is clear that the CTNs have raised points related to ‘Being a Nurse’. 
The CTNs describe their role as utilising their knowledge and skills from their nursing 
background and clinical speciality. The CTNs describe their experiences in their current role 
with some amount of frustration especially when discussing issues such as collegial support, 
role identification and education leading to career pathway. These issues are also reflection of 
professional nursing practice which identifies the CTNs as ‘Being a Nurse’ 
 
The analysis of the interviews highlights that CTNs utilise their nursing skills, knowledge, 
values, and expertise in their role in clinical trials research. In utilising their nursing 
background, the CTNs have demonstrated critical thinking and implementation of the nursing 
process in their roles. Nursing process is an integral part of nursing practice as it provides a 
framework and foundation for their practice which the CTNs have indicated throughout the 
interview. They describe their role in terms of being able to assess, analyse, plan, implement 
and evaluate situations as it arises. Thus providing leadership in the conduct of clinical trials 
and enhancing study integrity.  
These concepts are further expanded in the identification of the two subthemes Functioning 
within Professional and Ethical Nursing Framework and Applying Therapeutic Knowledge 
and Clinical Skills. These themes are significant because they contribute and expand the 
picture of being a Nurse, providing further understanding to the role that CTNs play in 
clinical trials research. 
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4.1.1 Functioning within a professional and ethical nursing framework 
The subtheme functioning within a professional and ethical nursing framework articulates 
how the CTNs enact their role, informed by their nursing knowledge and expertise 
underpinned by their nursing professionalism. The analysis of the interview text illustrates 
how the CTNs function from within a professional nursing framework which is guided by the 
Codes of ethical standards and practice that is both formally and informally a part of the 
nursing profession. This was evident in three ways:  the CTNs management of ethics and 
regulatory affairs, their engagement with the consent process and their handling of research 
data. 
 
The ethics process for clinical trials is rigorous and detailed, as described in Chapter Two. As 
for all clinical research, clinical trials  ethics applications require preparing documents such 
as consent forms and patient information sheets, liaising with ethics committees and 
assuming responsibility for follow up for the ethics submissions and reports as required by 
the ethics committee. All participants in this study identified ethics submission as part of the 
CTNs’ role in coordinating clinical trials research.  
 ‘I draw up all the relevant documents including ethics submission, which 
includes the clinical information and participation information sheets.‟ CTN 
Lara 
In preparing these documents, the CTNs identified that they require knowledge and ability to 
implement and monitor the study according to international standards for good clinical trials 
research practice and an in depth understanding of the study protocol. Some of the CTNs 
recognised that it was an area that required formal training which needed to be addressed. 
Others CTNs delved into their professional background of nursing and clinical expertise to 
understand the intricacies of a study protocol. 
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Following ethics submission, recruitment of patients into a study was identified by the CTNs 
as the next most important part of their role in clinical trials research. A key factor of the 
recruitment process that involves CTNs is their engagement with the consent process. The 
analysis of the interview data indicates that CTNs demonstrate professional nursing skills and 
leadership qualities in ensuring patient comprehension and safety during initial and ongoing 
clinical trial informed consent decisions. CTNs achieve this by going beyond simply 
providing information to the patients as they took their time to walk a potential trial 
participant  through the clinical trial process and communicating all aspects of the trial to the 
patient and their family or carer.  
 
Concurrently the CTNs performed a detailed assessment of all aspects of the patients’ 
medical and psychosocial history  in order to ensure that the patient was not only meeting 
clinical trial criteria, but was also able to participate and understand clinical trial 
requirements. This process of checking and ensuring that patients and their family are fully 
aware of their commitments is reflective of nursing practice whereby, nurses ensure that 
patient safety and comfort is maintained at all times. 
 
Communication skills were a key element of the informed consent process; while 
communication appears to be important in all aspects of the CTN role, it will be explored in 
detail in the discussion of the applying therapeutic knowledge and clinical skills subtheme. 
 
All participants outlined a detailed understanding of the informed consent process, describing 
elements of the process with reference to what it is, the assessment of patient understanding 
and knowledge, and who is responsible for gaining consent. There were mixed views from 
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PIs regarding the role of CTNs in obtaining consent. Four PIs stressed that it was ultimately 
the responsibility of the PI to gain consent from the patient as described by Ryan below, 
„No, I think that they [obtaining consent] should always be performed by a 
physician because informing people about side effects, I guess is an important 
part of consent and having seen side effects or treating people who have 
undergone complications because of drugs, I think that it is an important 
component to being able to provide consent and only a passing or only a 
theoretical awareness of side effects that are rare but catastrophic,...‟ PI 
Ryan 
The other six PIs had no problems with CTNs obtaining consent provided that the trial 
protocol did not require a PI to gain consent as indicated by Roger, 
‘in some studies I may consent the patient for the study, in others I may have 
a supervisory role where a nurse or an associated fellow consents the 
patient... It would depend on the requirement of the study and the expertise of 
the people who are around...‟ PI Roger. 
These six PIs described trust and confidence in the CTNs’ clinical knowledge as well their 
understanding of the clinical trial protocol as described by John, 
‘Yes absolutely, provided that they were appropriately trained and sensitive 
and you know all the things that good clinical trial nurses need to be.‟ PI 
John 
 
Of note, the CTNs stated that it was ultimately the PIs responsibility to gain consent from 
patients due to protocol needs, however two CTNs highlighted that they had a role in the 
process of obtaining consent, for example: 
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 „I feel that it is not so much the doctor explains that fully to the patient so I 
feel comfortable obtaining consent from the patient in the screening phase 
because I explain it very well to them, what it involves, the risks and the 
advantages and the benefits.‟ CTN Ann. 
 
Both groups of participants regarded the consent process as critical to the role of the CTN.. 
The analyses of the transcripts indicate that CTNs utilise their communication skills to help  
the patient and their family navigate through the informed consent process. The PIs identified 
that CTNs spent additional time with potential study participants in clarifying all aspects of 
the study therefore facilitating patients in their decision making process for consent, and 
acting as a liaison between the PI and the patient, described by one PI as: 
„So the trials nurse, I see it as a different person to help the family, patient‟s 
family to understand the clinical trial and the context of the trial.‟ PI Jade 
 
The CTNs highlighted that the requirement for informed consent is not merely met by 
completing a signed informed consent form: it is a process that requires participation from 
them and the patient as well as their family or carer. Steps in the process include taking the 
time to outline information to the patient so that the patient and family are fully informed and 
know what their responsibilities are to the clinical trial, for example: 
 
„..Really important, because obviously, people couldn‟t make a decision on 
one appointment and it was very, very important that they have a person that 
supports and explains what the trial is about and repeatedly do this and be 
available for them to understand before the person could then make an 
informed decision..‟ CTN Sherry  
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Similar thoughts were expressed by other CTNs in this study who were very passionate about 
how and in what context information about the trial was delivered to the patient. Analyses of 
the transcripts reveal that CTNs endeavour to maintain honesty in their information transfer 
and allow for clarification of all issues that would impact upon the patient as a person..  In 
this way, they are counselling participants on what to expect during their participation in the 
trial, as evidenced by the exemplars below: 
„I think I‟m more honest. The head and neck (cancer patients) especially, I 
sit down and take time [with] them. The treatment is horrific. I don‟t think 
anyone says that to them but I actually say to them, “You have a really 
difficult road ahead of you and mentally you have to prepare for that.” And I 
think that is important and I don‟t think anyone says that and I have never 
ever heard a doctor say that to them. It is assumed…‟ CTN Bal 
 
‘…I just don‟t think that they [PI] tell patients the full extent, the possible 
side effects or outcomes from what they [patients] consent to, just from 
getting patient feedback, when they get sentinel node biopsy surgery and wide 
excisions, you ring them up a week later and they say, “I am in so much pain, 
the doctor did not tell me that I will be in so much pain.” And that has come 
through quite a lot and the doctor has told them, “Oh! You will be sore for a 
couple of days and you will be right as rain.” Or “You will back at work in 2 
days.” It is a week later and the patient is still taking Panadeine. I think that 
had definitely come through, that they are not given, things are skimmed over 
like or I mean we are all health workers things become routine but for the 
patients it is not routine, it is a big thing and I think doctors could be 
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dismissive, not all of course, but they can be dismissive of what it actually 
entails.‟ CTN Ann 
 
Another important factor to emerge from the analysis of the interview text is the recognition 
of the vulnerability in patients by the CTNs. Some of the CTNs expressed concern in regards 
to patients’ emotional and mental status when discussing clinical trials study participation.  
 
Mel reports that patients were often traumatised when they hear their diagnosis of cancer, 
therefore are not able to absorb and digest information in regards to clinical trials 
participation, 
‘They have had very traumatic news, they are anxious, all those things that 
come with having a diagnosis of malignancy. So when patients ask me things 
and I think you should have heard this, you should have been discussing this 
fifteen minutes ago when you were in whoever‟s office. I also have to factor in 
that they may have and they may just not have absorbed it.‟ CTN Mel. 
She further describes how she feels conflicted that the responsibility becomes hers to ensure 
that the patient receives the right information, 
„Generally my main concern is that I do feel the weight of the responsibility 
of conveying the accurate and the correct information to them and I do not 
think it is my sole responsibility. I know it is not my sole responsibility to do 
so. I guess sometimes I think I would like to have some reassurance that it is 
also coming from the medical side.‟ CTN Mel 
 
The analyses of the interview text indicates that CTNs face many challenges in regards to 
disclosure and the quality of information transferred  and how this impacts upon the safety 
83 
 
and comfort of the patient. CTNs reported that they were able to make a judgment and take 
appropriate actions to ensure the safety and comfort of the patient using their nursing skills of 
assessment. CTNs stated that they endeavoured to be present when the patient is first 
introduced to the idea of clinical trials in order to gauge a patient’s understanding and assess 
their emotional status from the outset. They also spend an extended time with the patient and 
their family discussing the trial and being available to them for questions and importantly 
arranging further consults with PIs as soon as possible for clarification and signature of 
consent forms.  
‘I think that the only thing we can do is to act as that go between and talk to 
the patient and make sure that if they do have any questions, to write them 
down and that the doctor is there for them, they are not to feel that they are 
being rushed and that, you know, they have to take the time to, you know have 
their questions answered...‟CTN Ann 
 
The analysis of the interviews identified other challenges relating to patients’ rights in 
clinical trial research. For example, Cris found herself in a situation where the patient’s 
ability to consent was compromised:  
„….. there was a patient who has an intellectual disability...some recent 
health drug issues as well and I was not certain about his intellectual 
capacity to digest that nine pages of information and to make that decision so 
I brought his case to... we have a regular weekly meeting with our 
psychiatrist and our team and ask their opinion, you know, discussed him in 
detail and got them to have a look at him and to assess his ability to give 
legal consent.‟ CTN Cris 
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In other cases, however, the CTNs do not involve others to resolve ethical dilemmas. While 
CTNs acknowledge the value of clinical trials research for the advancement medical 
knowledge and the development of new and effective therapies, they expressed their primary 
obligations to ensure the safety and welfare of individual patients in their care. An example of 
this is when patients ask for a nurse’s opinion about a  trial. CTNs maintained that their role 
was to facilitate the patient’s choice to enter a clinical trial without any bias or coercion. For 
example, Rina related a patient discussion: 
‘[The patient asks] “What will Professor K do if I don‟t go on this study.” 
“Absolutely nothing”.... and the nurse, in our role we are providing the space 
for them to make that decision.‟ CTN Rina 
 
While CTNs understand that there are regulatory requirements governing clinical trials 
research, they appear to be influenced more strongly by the ethical frameworks of the nursing 
profession rather than the research frameworks of the clinical trial. . John, one of the PIs gave 
an example where the CTN did not want to recruit a patient because there was a language 
barrier on the patient’s part, he stated:  
‘…one of our CTNs was not comfortable that the patient‟s English was good 
enough to understand, I thought it was and she felt it wasn‟t, so we are 
getting a third opinion…[laughs]…and talking to the relatives who weren‟t 
present at that time...it hadn‟t occurred to me that she had any particular 
difficulty with English, she thought that.‟ PI John 
The CTN insisted that they obtain another opinion and speak to the patient’s relatives before 
deciding to recruit the patient into the clinical trial. 
 
85 
 
Although the PIs maintain that allowing for another objective view on the consent process is 
good practice, not all of them agree who has ultimate responsibility for refusing a patient 
entry onto a trial. I Megan states for example that the final decision should be taken by the PI:  
‘...it is not their role [CTN] to say, “I think that you should stop this trial on 
this patient because of this and this...” I mean they may and I guess the 
clinician has to take that in consideration but I don‟t think it is actually their 
role to say, “I think you should stop it on this patient.” I think that their role 
is to present all the information saying, “This is all the complication this 
patient has had, this is how bad it is, what you want to do?” It is an approach 
rather than single handed say, “This is what I think is for the patient.” PI 
Megan. 
 
The analysis of the transcripts illustrate that the clinical and assessment skills of CTNs are 
important for demonstrating knowledge of each designated clinical trial protocol, including 
the procedures and documentation necessary to ensure the safe and accurate conduct and 
recording of data and study outcomes:.  
‘..advanced skills that the nurses have...also means that the follow up in the 
data collected is much truer to the outcomes of the study, which is extremely 
important when you are talking about the ethical nature of human research.‟  
CTN Rina 
The CTNs ensure that data is recorded accurately and in accordance with regulatory 
requirements by adhering to guidelines and study specific documentation. This reflects the 
CTNs’ understanding of the clinical implications of accurate recording and management of 
data which is drawn from their nursing standards of practice. CTNs engaged in the collection 
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of clinical trials data obtain and validate clinical results, for example pathology related to the 
particular clinical trials study, and sometimes handle tumour tissues or pathology slides:  
„is a lot of paper work, keeping up to date on patient records, entering details 
into patient‟s database, doing electronic CRF [Case Report Form enables 
collection of data in a consistent manner, available both in paper and web 
base] entry, de identifying pathology slides and sending them to the USA and 
also reporting adverse events.‟ CTN Ann 
The analysis of the interview text exemplifies how CTNs function from within a professional 
nursing framework guided by the ethical standards and practices of the profession to maintain 
integrity and confidentiality in the process of data collection and management. 
 
In summary, it appears that both CTNs and PIs participating in this study agree that essential 
criteria for the CTN role include helping to identify potential patients for studies, recognising 
those who may not be able to give informed consent or complete a study for reasons that 
might not be evident in the protocol, ensuring that the patient and their important family 
members are included in decisions, that all aspects of the participation in the study are clear 
during the consent process, that data collection and management of the conduct of the study 
is maintained within ethical frameworks and guidelines. This is an area where the CTNs’ 
professional knowledge and skills as a nurse came to the fore. CTNs can assess patients for 
entry to clinical trials using their professional nursing skills which are underpinned by ethical, 
legal and moral obligation to the patient to ensure that patients’ rights and welfare are 
protected, essentially practicing from within their professional nursing framework and Codes 
of Ethics and Professional Conduct as outlined by the Australian Nursing and Midwifery 
Council. 
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The next section will explore the theme of therapeutic knowledge and clinical skills in 
clinical trials practice. The exploration of this theme reveals how CTNs further enact their 
role within a nursing framework. 
4.1.2 Applying therapeutic knowledge and clinical skills 
Analysis of the interviews revealed how CTNs draw on their nursing skills and knowledge to 
practice as a CTN. While not a surprising finding, the degree to which the nurses functioned 
as a nurse working in clinical trials, rather than a clinical trials nurse, was greater than 
anticipated. Each of the CTNs participating in this study worked in a research role that 
required interaction with patients. All participants worked on medical-led trials where a drug 
or surgical intervention was being investigated.  
 
None of the CTNs participating in this study had responsibility for the provision of direct 
patient care for the study participants. Yet across all CTNs in this study there was evidence of 
interaction with clinical trials participants in a therapeutic nursing relationship. These were 
not components of the trial protocol. While some trials required the CTNs to use their nursing 
skills, for example venepuncture and physical assessment, both participant groups identified 
the nursing knowledge and understanding CTNs brought to clinical trials as a factor related to 
the success of the trials. 
  
The nursing knowledge reported as making a significant contribution to clinical trials by the 
CTNs includes disease and treatment knowledge in both general and particular clinical 
specialties. Clinical skills that the participants describe as contributing to the success of the 
trial comprise of nursing clinical skills, for example phlebotomy, medication administration, 
interpreting test results and equipment handling. Both groups of participants in this study 
report that the CTNs utilise their nursing knowledge and clinical skills in critical thinking and 
88 
 
decision making, facilitating and maintaining relationships with patients and PIs, and in their 
assessment of patients’ suitability for clinical trials research. 
 
One of the key sub-themes to emerge from the interview text was the value of the 
communication skills of the CTNs. These were highlighted by both the PIs and the CTNs. 
Analysis of the interviews demonstrates that CTNs have superior communication skills which 
have developed during their nursing backgrounds and which they utilise in clinical trials 
settings. The communication skills of the CTNs were described as an all- encompassing 
factor in the management and coordination of clinical trials research. Participants of this 
study described the communication skills of CTNs in terms of establishing a good 
relationship between patients, PIs and CTNs, establishing a working relationship with other 
health care professionals and departments as required, maintaining relationships with patients 
and colleagues throughout course of clinical trials and using their interpersonal skills to 
manage clinical trials as a whole. 
Participants described that CTNs facilitated lines of communications that intertwined 
throughout the whole clinical trials research process:  
‘...one of their major roles is just, organising the whole process,  important 
role is communication throughout the whole, that period of time when the 
patient is enrolled and identifying any problems that the patient has as a 
result of being on the trial, that is important.‟ PI David 
 
As the exemplar above indicates, communication occurs from the initiation of the clinical 
trials and follows through with recruitment of patients and managing patients throughout the 
whole clinical trial. In recruiting and managing patients on clinical trials, both groups of 
participants stressed the importance of communication skills and the PIs in particular relied 
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upon the CTNs to maintain relationships with patients and facilitating the PI and patient 
relationship. Analysis of the interviews indicates that CTNs act as an intermediary between 
the patient and PI by being proactive in anticipating issues and ensuring that protocols and 
procedures are met: 
‘they [CTNs] have a big impact, in bringing the patient and doctor closer 
together,….communicating any potential problems to the patient and also 
encouraging the patient to communicate more with the doctors.‟ PI David 
 ‘…they [the CTN] come to me with any problem and are excellent at 
communicating with the patient and myself so that they are very on the ball 
and in some cases remind me to do certain things that I forgot to 
do![Laughs]… which is great and it actually makes me feel much more 
comfortable about running the trial because I know that they are on top of 
things.‟ PI Megan 
 
CTNs have already learnt to work collaboratively with multidisciplinary teams in the clinical 
setting from their nursing experience. Participants in this study reported that CTNs 
maintained lines of communication with a wide range of people during the set up and conduct 
of clinical trials. Apart from the clinical trial research team, CTNs described that they liaise 
with hospital personnel such as radiology and laboratory staff, with ethics committees, 
clinical trial sponsors and trial monitors.  
 
Analysis of the transcripts also illustrates that the open dialogue between patients and CTNs 
creates an environment for integrated care throughout the clinical trial process, as described 
by Mel: 
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‘...nothing happens in a trial unless you have effective communication 
between trial staff and your patients and better that communication role in 
those relationships are... the better your running of the trial is, your data is 
cleaner, your recording is better, your compliance with the trial procedures 
is better, patients are happier with their trial participation and their general 
care.‟ CTN Mel 
 
The interviews highlight that CTNs establish rapport with patients and develop a trusting 
relationship by listening, being responsive to patient’s needs, portraying an interest in the 
patient, clarifying information in a manner that the patient understands and providing 
information when consulting with patient. Mel describes how listening skills are important, 
especially in the context of gaining consent. She presents here as an active listener, interested 
in what the patient has to say without making any judgements and providing them time to 
make their decision. 
‘Listening is very important, patients need to feel that they can talk things 
through,... a matter of just listening what they are considering, therefore the 
consent process is easier and they come to that decision in their own time.‟ 
CTN Mel 
This is not very different to the clinical setting where nurses establish relationships with their 
patients in order to know them better in order to provide more effective care for them. This 
suggests that patients may feel more comfortable discussing issues with CTNs rather than 
their doctors or PIs of clinical trials:  
‘... you are spending more time with them so you get to know them better and 
you build a bit of a rapport and sometimes they would tell you things that 
they wouldn‟t tell the doctor‟ CTN Vicky  
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CTNs report that at these initial stages of building relationships with trial participants, skills 
such as listening and being attuned to patients’ needs are important as they can lead to 
positive outcomes as described by Ann who coordinates an international multicenter clinical 
trial study: 
„Because nurses tend to have good communication skills and talk to people 
and I mean that is something that we got back from, with the trial after 12 
months, the monitors came out and we are doing well at our site because we 
[CTNs] can talk to people, we‟ve got good people skills and people can relate 
to us.‟ CTN Ann  
 
The interview data in this study suggests that CTNs apply their therapeutic knowledge base 
and cognitive, critical thinking and decision making skills to supporting patients through their 
clinical trial journey.. Both groups of participants in this study maintained that CTNs utilise 
their clinical skills to assess a situation, tune-in to the needs of the patient and help and 
support the patient as need arises. CTNs use the knowledge obtained from forming 
therapeutic relationships with their patients to develop and implement strategies related to 
patients’ health and welfare, such as informing them on matters related to their clinical status.   
A common pattern to emerge from the interview data was where CTNs view the patients’ care 
as more than that required or mandated within the clinical trials setting:  
 ‘someone was having quite a lot of symptoms that weren‟t so obvious when 
they came to appointments, you might say well then, bring the palliative care 
team in or there is somebody who is older, decrepit or fatigued, you could do 
something like get high seated toilet, just meet their occupational therapist 
and that type of thing, make their circumstance a bit better in the process.‟ 
CTN Sherry 
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 „..and the understanding of the disease process and a medical/nursing 
understanding helps also in terms of trial work, things aren‟t cut and dry, 
things aren‟t concrete for patients and the information that they get is often 
vague and non specific and they are dealing with a lot of uncertainty..‟  CTN 
Mel. 
 
Together with their knowledge of the healthcare system, hospital policies and procedures and 
the workings of interdisciplinary care, CTNs effectively manage the needs of trial patients as 
supported by the exemplars below: 
‘..those advanced skills that the nurses have… understanding the disease process, 
being able to do those assessments and refer appropriately means that you are 
actually getting your patients to stay on the study.‟ CTN Rina 
„You are one of usually a number of health consultants that they are seeing [the 
patient] at the same time, so they have their GP, so you would coordinate from the 
point of view of the study…. refer them to someone more appropriate‟ CTN Vicky 
 
The CTNs claimed that it was not only their experience in the clinical trial speciality that was 
helpful, as their general nursing and other clinical speciality training became useful when 
dealing with patients on clinical trials as exemplified by Sue: 
‘…you need nursing knowledge to actually do clinic work for a number of 
trials, for in MS you can say well what do you need, neurology or whatever, 
well I have cardiothoracic background and I cannot tell you how handy that 
is, I mean I use it non stop and it is to the advantage of the trial really, we do 
pulmonary function tests, chest X-Rays, we do ECGs, you know I can look at 
those and I know instantly if there is a problem…‟ CTN Sue 
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The PIs also identified this aspect of the CTN role as important.  The PIs stated that the 
ability of CTNs to identify medical problems, understand disease processes and the treatment 
under investigation were invaluable qualifications and background for the role of clinical trial 
coordinator:  
‘I think a nursing background, because just going back to the point of them 
needing to have some clinical, nursing background looking after patients 
before…Nursing background is also good because people tell you about 
medications and you should be able to understand what they are talking 
about.‟ PI Jane 
Analysis of the interview data obtained for this study  highlights that CTNs utilise their 
critical decision making skills, evaluating the patient’s history and personal situation before 
consulting with them  regarding their final decision on trial participation. CTNs indicated that 
recruiting patients into clinical trials required more than just meeting clinical trials criteria 
and protocols; there are psychosocial and physical needs of the patients that also should be 
addressed. In performing their clinical assessment, CTNs are working from within their 
nursing framework which is also about a duty of care to the patient as described below: 
 ‘a patient, he was encouraged to go on the study, I went up to see him… 
talked to him for a while, he was really keen to go on the study, older 
gentlemen…he was also his wife‟s carer, just wasn‟t practical for him to give 
us the time that I was asking of him, so in that case, I am more than happy to 
say , “Look we would loved to have you on the study but in your situation, I 
understand that you are the carer for your wife and time is an issue.” He 
agreed.‟ CTN Bal 
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Within the therapeutic knowledge and clinical skills subtheme, the participants of this 
study have described and highlighted how their nursing therapeutic knowledge and clinical 
skills is utilised in their clinical trials role. The CTNs describe how they utilise their extensive 
nursing background to assist in decision making in regards to patient care and their safety. 
The analysis of the transcripts illustrates that CTNs facilitate and maintain relationships 
between patients and PIs by establishing a rapport with patients to create a supportive and 
trusting environment for the patients throughout their clinical trials journey. This aspect of 
their role, together with fulfilling CTN tasks within a professional and ethical nursing 
framework, contributes to the understanding of the CTN role as ‘being a nurse’. 
4.2 Conclusion 
It is evident from the analysis of the interview data that the CTNs practice within a nursing 
framework. The CTNs describe their clinical trials practice from within a professional 
nursing domain. These descriptions include autonomous practice and advanced negotiating, 
communication, interpersonal and leadership skills. The CTNs accomplish this by drawing 
upon their professional nursing and ethical background. The analyses of the transcripts 
indicate that CTNs utilise aspects of the nursing process to assess, implement and evaluate 
their decisions in relation to gauging a patients’ understanding of clinical trial requirements 
and the clinical trials journey. This is reflective of functioning from within a professional and 
ethical nursing framework. 
The second subtheme further illustrates how the CTNs are ‘Being a Nurse’. The CTNs 
clearly describe and explain how they use their therapeutic knowledge and clinical skills to 
integrate into the clinical trial coordinator role. The CTNs indicate that they apply their 
therapeutic knowledge and clinical skills to assist the patient in making their trial journey as 
comfortable as possible. The CTNs point out that they are able to do so because they bring 
forth their extensive nursing background to help patients understand the intricacies of trial 
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requirement by listening, helping patients understand the disease process, caring for their 
multitude of social and health problems and being able to refer them on appropriately within 
the health system. In creating this safe and comfortable environment, the CTNs form lasting 
relationships with their patients and the clinical trials team, which in turn as stated by the 
CTNs ensures good participation leading to good outcomes for any clinical trials. 
 
In conclusion, the CTNs have demonstrated through the two subthemes that they are, ‘Being 
a Nurse’. 
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Chapter 5: Discussion 
5.0 Introduction  
The aim of this research study was to investigate the role of clinical trials nurses (CTN) in 
Australia. The research question: ‘What is the role of registered nurses in clinical trials 
research in Australia?’ was explored using a Gadamerian hermeneutic approach. Through the 
analysis and interpretation process, themes emerged from the interview data, forming a 
comprehensive picture of the CTN experiences and understanding of their role in clinical 
trials research. This chapter discusses the themes that emerged from this study in relation to 
current and past research and relevant scholarly literature where available. 
 
One overarching theme ‘Being a Nurse’ and two subthemes: ‘Functioning from a 
Professional and Ethical Nursing Perspective’ and ‘Therapeutic Knowledge and Clinical 
Skills’ emerged from the analysis of the interview transcripts. Being a Nurse explores how 
the CTNs view themselves and how PIs view the CTNs in their clinical trials role, 
specifically the utilisation of their knowledge, skills and professional nursing background. 
This theme also encompasses the challenges faced by CTNs in an ambiguously defined role 
that they still considered to be a nursing role, yet lacks a clear career pathway. This major 
theme is further expanded by the two subthemes. 
 
The first subtheme, Functioning from a Professional and Ethical Nursing Perspective, 
describes CTNs working from within a professional nursing framework underpinned by 
ethical practices as guided by the Australian Code of Ethics for Nurses which provides a 
framework for accountable and responsible nursing practice (Code of Ethics for Nurses in 
Australia, 2005). The second subtheme, Applying Therapeutic Knowledge and Clinical Skills, 
describes how CTNs draw upon their clinical knowledge of assessment, planning and 
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evaluation in clinical trials research coordination and management, and employ a range of 
interpersonal skills to facilitate relationships between patients and the clinical trials research 
team. The themes found through the analysis of interviews in this study cannot be considered 
individually or in isolation, but together to provide a picture of how CTNs and Principal 
Investigators (PIs) of trials interpret the role of the registered nurse in clinical trials research. 
5.1 Being a Nurse 
The findings of this study demonstrate that both CTNs and PIs view CTNs as nurses working 
in a clinical research role, with their professional identity, knowledge and skills as nurses 
being central to the CTN role. Throughout the interviews conducted in this research study, 
the CTNs identified themselves as nurses and not as researchers. Furthermore, the CTNs 
often described their nursing colleagues conducting clinical trials research as „the nurse‟ or 
„nurses‟. PIs likewise referred to the CTNs as ‘nurses‟ when describing the roles and 
responsibilities of the CTNs, at times addressing CTNs as clinical nurse consultants or 
clinical nurse specialist. This reiterates the notion that the PIs see the CTNs in a specific 
professional light and recognise them first and foremost as nurses. 
Fagermoen (1997) refers to professional identity as the nurse's conception of what it means to 
be and act as a nurse and how a nurse’s philosophy of nursing is represented. By consciously 
reaffirming their professional identity, the CTNs appear to hold a connection to everyday 
nursing practice and this identity was evident in the examples the CTNs and PIs provided in 
the course of the interviews. Hence, this professional identity as an expression of the values 
and beliefs held by the CTNs, guide their thinking and actions within their role.  
 
In addition to retaining a professional identity as a nurse, CTNs also appeared to value their 
nursing background and experiences and realise their applications in a clinical research 
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setting. For example, the CTNs would constantly refer to how their nursing background and 
experiences supported their decision making process in clinical trials management, facilitated 
relationships between themselves, patients and PIs, and helped overcome situations or 
challenges encountered in their CTN role. These references were echoed in the PI interviews, 
where the PIs indicated that someone from a professional nursing background provided 
research teams with an in-depth knowledge base and cognitive, critical-thinking, and 
decision-making skills that was beneficial to their research.  
 
The attributes that the PIs refer to are reflected in the nursing competency standards and 
practices that are outlined by nursing bodies around the world. The Australian Nursing and 
Midwifery Council (ANMC), the peak national body for nurses and midwives in Australia, 
has set national standards for the educational preparation of nurses since the early 1990s 
(ANMC, 2006). These standards are presented as domains which all nurses in Australia are 
required to demonstrate in order to practice as registered nurses. These domains are 
professional practice, critical thinking and analysis, provision and coordination of care and 
collaborative and therapeutic practice (ANMC, 2006).  
Professional nursing practice can be described as having a patient-centered focus, being 
accountable for practice, and making sound judgements based on experience and knowledge 
thus acting within the legislative framework of nursing and health care (ANMC 2006; Girard, 
Linton & Besner 2005). The CTNs in this study discussed how they coordinated trial patient 
care by utilising their clinical experience and knowledge to make clinical and non-clinical 
judgements. For example, the CTNs were able to review and interpret pathology results and 
electrocardiogram (ECG) and alert PIs to any abnormal results. The CTNs further discussed 
how they collaborate with other departments in coordinating patient care based on their 
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professional knowledge, for example utilising social workers, diabetes educator and 
community nurses. 
They also described being accountable for their own practice while acting within the 
scientific, legislative and ethical requirements of clinical trials research. It was highlighted 
during the interviews and in the literature review (Chapter 2) that the successful conduct of 
trials hinges upon vigilant implementation of regulatory aspects and clinical protocol (Nagel 
2010; Catania et al.,2008; Rickard et al., 2006). Drawing upon their experience in diverse 
clinical settings and backgrounds, the CTNs were able to autonomously make decisions in 
clinical care of the patients. The CTNs were constantly aware of their accountability when 
making decisions thus acting within the needs of clinical trial protocol as well as good 
clinical practice. However, there were times that the CTNs felt that the clinical trial protocol 
did not suit the patients and raised this issue with the PIs for example treatment regime and 
the overall benefit to the patient. In addition the CTNs utilised their professional knowledge 
and experience to provide clinical and emotional support and education to patients and staff 
involved in the trial process (Bell 2009; Bird and Kirschbaum 2005).  
The CTNs also outlined the need for more education in aspects of their role, particularly 
those involving regulatory aspects which their clinical nursing background did not prepare 
them for. Suggestions presented by the CTNs included provision of training and education for 
research skills and preparing a clear career pathway to clinical trials nursing which included a 
set of national competencies similar to those developed for other nursing specialties such as 
cancer or palliative care nursing. 
The domain of critical thinking and analysis within the Australian competency standards 
relates to ‘self-appraisal, professional development and the value of evidence and research 
for practice‟ (ANMC p2, 2006). Within this domain, the registered nurse is able to continue 
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developing their current knowledge base, share it with other health professionals and nursing 
colleagues and provide critical thinking in decision-making (ANMC 2006; Girard, Linton & 
Besner 2005). The CTNs in this research study demonstrated how they utilised critical 
thinking in their decision-making process in terms of coordination of care of the patient 
which included the ability to use evidence gathered through both professional and personal 
experience. Provision and coordination of care defines the ability of the registered nurse to 
coordinate, organise and provide nursing care that includes the assessment of individuals and 
or groups, planning, implementation and evaluation of care (ANMC, 2006).  The nurses in 
this study defined their role in terms of being responsible for assessing eligible patients for 
the trial, enrolling, obtaining informed consent, administering and monitoring study treatment 
and the progress of patients, as well as being involved in patient education and overall 
coordination of care of patients whilst in clinical trials.  
Similar to competencies required for critical thinking and analysis, the provision and 
coordination of care domain also involves the CTNs engagement in creative problem solving 
as well as evaluating and questioning outcomes and inconsistencies. Both CTNs and PIs 
described situations where CTNs actively questioned patient eligibility and challenged the 
validity of placing certain patients on clinical trials. The CTNs worked within an appropriate 
ethical framework and used clinical judgement and decision-making skills to coordinate and 
manage challenges in their role as encountered. 
Collaborative and therapeutic practice refers to „establishing, sustaining and concluding 
professional relationships with individuals and or groups‟ (ANMC p2, 2006). CTNs in the 
study referred to the importance of having confidence in their ability and taking responsibility 
for their actions, including having a comprehensive understanding of the professional 
boundaries and limitations of nursing practice. On the other hand, the CTNs in this study 
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described that their practice can only grow with collegial support (which they currently saw 
as lacking in Australia). The CTNs revealed that at times, their role was not acknowledged as 
a nursing role, particularly by nursing colleagues and Australian nursing bodies themselves. 
This in itself leads to a dilemma of where CTNs stand in the professional  practice of nursing 
as there is no national recognition of their role in nursing legislation, therefore no set 
guidelines for  their specialist practice and no avenue for the CTNs to discuss and solve 
professional practice issues they see as specific to their role. 
Eaton and Pratt (1990, p 138) state empathetically that nurses employed in the role of trial 
coordination ‘play the pivotal role in the daily conduct of a clinical trial’. The authors, 
(medical practitioners) describe further how they recruited nurses from specialist clinical 
backgrounds, and provided training to fulfil trial coordinator positions, suggesting that this 
route would lead to more successful trial conduct. Thus, the overarching theme of Being a 
Nurse found in this study demonstrates that CTNs utilise their nursing skills and expertise to 
positively contribute to clinical trials research, which is recognised and seen as beneficial by 
both CTNs and PIs.  
In the following sections, further understanding of the role that CTNs play in clinical trials 
research, will be discussed though the two subthemes which contribute and expand the 
overarching theme of Being a Nurse. 
5.1.1 Functioning from a Professional and Ethical Nursing Perspective 
The subtheme comprises the description of the CTN role from a professional and ethical 
nursing perspective. As noted in Chapter 4, this was evident in three areas: 1) managing 
ethics and regulatory affairs, 2) involvement in the informed consent process, and 3) handling 
of research data. As indicated in Chapter 4, involvement in the informed consent process 
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sometimes raised ethical dilemmas for CTNs relating to research goals and patient 
recruitment, and concerns regarding the patient’s ability to provide informed consent. The 
discussion of this subtheme provides a further insight to the role that registered nurses play in 
clinical trials research. 
The PIs in this research study described how important it was for anyone transitioning into 
the role of clinical trials coordination to understand the concept of research and its place in 
society, therefore demonstrating a commitment to clinical trials research and its underpinning 
philosophy. Some of the CTNs indicated that although they are aware the main objective of 
their position was in the recruitment and retention of patients to clinical trials, their main 
concern, however, is for the patient. Here the CTNs clearly demonstrate that they are being 
nurses, wherein they are projecting a caring attitude and a willingness to meet the patients’ 
needs rather than the needs of the clinical trials. These actions by the CTNs may not always 
align with the research objectives and can therefore lead to tension between CTNs and PIs or 
trial sponsor.  
Previous literature about CTNs has acknowledged the tension between the dual role of 
caregiver and researcher (Fisher 2006; Davis et al., 2002; Ecklund 1999; Di Giulio 1996; 
Johnson 1986). From the interview data analysed in this research study, a clearer indication 
emerges that the CTN fulfils several roles in clinical trials coordination and management, of 
which a major role in the informed consent process is apparent. Additionally, the results 
indicated conflicting interpretations between PIs and CTNs as to who had the ultimate 
responsibility for patient consent. The informed consent process also contributed to the 
tension between caregiving and research roles for CTNs; for example, CTNs in this study 
frequently expressed concerns to PIs that clinical trial protocols may not sufficiently consider 
patient needs.  Specifically, CTNs in this study stated that they had indicated their concern 
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about the suitability of the clinical trial to individual patients when implementing a trial 
protocol and questioning whether or not the patient would benefit from participating. Some of 
the examples given by both CTNs and PIs in this study included consideration of the social 
and emotional wellbeing of patients, language barriers and physical requirements such as 
travel to the clinical trial site for protocol driven assessments. 
 
Although the CTNs in this study understood the importance of enrolling and recruiting 
patients onto a clinical trial, they often described themselves as advocating on behalf of the 
patients and all of the CTNs identified patient advocacy as their primary responsibility. 
Previous studies have indicated that CTN commitment to patient welfare translates into an 
advocacy for the patient that follows on throughout the study and remains a central role for 
the CTN during the course of the clinical trial (Fisher 2006; David et al., 2002). Advocacy is 
an important concept in nursing practice and is frequently used to describe the nurse-client 
relationship (Gaylord and Grace 1995; Gadow 1990). For nursing, patient advocacy is not 
limited to the defence of patient rights, it stems from a philosophy of nursing where nursing 
practice is to support a patient to promote his or her own well-being, as understood by the 
patient (Gaylord and Grace 1995). Thus, the commitment to patient advocacy illustrates how 
CTNs function from a professional nursing perspective.  
 
The views of the CTNs in this study regarding informed consent highlighted how their 
research roles were grounded in ethical nursing practice and knowledge. CTNs perceived 
informed consent as a complete process and paid particular attention to delivering 
information and clarifying the impact of trial participation on the patient. Consistent with the 
literature, CTNs saw themselves not only recruiting participants, but also providing care to 
those patients recruited to the trial (Mueller and Mamo, 2002) utilising the values, ethics and 
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beliefs consistent with  Being a Nurse. Nursing background, professional knowledge and 
ethical principles therefore informed their practice as a CTN. 
Previous studies have indicated that CTNs understand how their role influences the informed 
consent process, and particularly how the quality of their interaction with the patients affects 
patient recruitment, enrolment and retention in clinical trials (Fisher 2006; Wright et al., 
2002). Most of the PIs agreed that having a nurse in the role of clinical trial coordinator was 
advantageous. The PIs expressed this aspect because they noticed that nurses functioned from 
within their professional nursing background which included developing and maintaining 
trust and rapport with patients. One PI in this study stated that nurses should be utilised if the 
clinical trials were of a complex nature because nurses would be able to apply their critical 
thinking and ethical judgement to the clinical trials research process. The CTNs in the study 
described the importance of maintaining rapport with the patient to ensure the continuity of 
their trial participation. Continued participation of patients on clinical trials to completion is 
crucial because this delivers important data at the end of the study necessary for testing the 
effectiveness of the intervention (Friedman et al, 2010) 
Despite the fundamental role that CTNs play in the informed consent process, they are often 
left out of discussions regarding ethics in clinical trials at the protocol design stage (Fisher 
2006; Wright et al., 2002; Tattersall 2002). This is unfortunate as involving CTNs from the 
initial stages of clinical trial protocol development also enables CTNs to contribute towards a 
more patient-friendly study design (Davis et al 2002; Ocker and Plawik 2000). A few studies 
(Loh et al., 2002; Davis et al., 2002; Tattersall 2002; Wright et al., 2002) have reported in 
both the medical and nursing literature on the positive influence that CTNs have in the 
informed consent process. These studies have suggested further investigations are needed to 
evaluate the full impact that CTNs have upon the informed consent process in clinical trials 
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research. Further research will evaluate whether nurses utilising their professional nursing 
background have a positive impact to the informed consent process. The next section will 
discuss the second subtheme found in this study; therapeutic knowledge and clinical skills. 
5.1.2 Applying Therapeutic Knowledge and Clinical Skills 
Registered nurses are able to make a unique contribution to the conduct of clinical trials as 
they are able to marry their clinical nursing knowledge and skills with research skills within 
the particular therapeutic discipline of clinical trials practice. CTNs provide quality of care 
for patients and their families by applying their knowledge of disease and symptom control 
and their nursing skills in clinical decision making and problem solving to the care of patients 
enrolled on trials. This section discusses how CTNs apply therapeutic knowledge and clinical 
nursing skills within their clinical trials nursing role.  
CTNs in this study reported constantly assessing their patients, monitoring them and deriving 
clinically related data as well as research data related to the clinical trial. This exemplifies 
CTNs using the therapeutic knowledge and clinical skills that they bring into the clinical 
trials role (Nagel et al., 2010;Hill and MacArthur 2006) and how these are grounded within 
their professional nursing framework. The skills and characteristics related to providing 
nursing care identified in the nursing literature are also displayed by CTNs in their role in 
clinical trials. McCance (2003) summarises these skills as professional competence, 
interpersonal skills, personal characteristics and commitment to the job.  
CTNs portray these skills and characteristics through the various aspects of their role, for 
example when they are performing technical aspects like venepuncture, physical assessment, 
educating patients, listening to them, being friendly and open and showing interest in the 
patient and their background (Nagel et al., 2010; Hill and MacArthur 2006; Roberts et al., 
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2006; Rico-Villademoros et al., 2004; Mueller and Mamo 2002). Professional competence in 
nursing focuses on the skills of the nurse in relation to the physical or technical aspects of 
care and the ability of the nurse to prioritise their work load as perceived by the patient 
(McCance, 2003). Nurses stepping into a clinical trials role are often from a clinical specialist 
background and have extensive clinical expertise and experience, therefore bring with them a 
wealth of knowledge and clinical skills that they can utilise in their clinical trials nursing role 
(Roberts et al., 2011; Bell 2009; Hill and MacArthur 2006; Rickard et al., 2006; Rico-
Villademoros 2004).  The PIs in this study, as well as other studies reported in the medical 
literature (Wright et al., 2002; Loh et al., 2002; Eaton and Pratt 1990) state that CTNs are 
employed in trial coordinator positions because they demonstrate this combination of 
professional expertise and skill. 
 In demonstrating professional expertise and experience, the CTNs depict confidence in their 
work which patients observe, and therefore may potentially lead to enhanced clinical trials 
participation. McCance (2003) identified links between professional competence and the 
experience of the nurse as an influencing factor on the confidence engendered in the patient. 
Mueller and Mamo (2002) give examples of how CTNs in their study provided care by 
performing nursing functions such as physical assessment, education and advocacy and 
connecting with their patients on an emotional level. Another example that these authors 
describe is how CTNs use their interpersonal skills to get to know their patients to develop 
and implement health education strategies (Mueller and Mamo 2002). 
The effective use of interpersonal skills was described by the CTNs and PIs participating in 
the current study as an important contributing factor to the successful conduct of clinical 
trials. CTNs use their interpersonal skills in the role of educator for the patient and family, 
and for other healthcare professionals associated with the clinical trial (Bell 2009; Ocker and 
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Plank 2000). Utilising their knowledge in disease and symptom management, the CTNs 
convey information in an environment that is supportive and safe.  
. 
The CTNs enable the process of creating a supportive and safe environment by providing 
patients time and assurance during the informed consent process (Poston and Buescher 2010; 
Fisher 2006). The CTNs have an obligation to provide safe and supportive care as it is part of 
their professional nursing undertaking. They are able to draw upon their nursing knowledge 
and skills to ensure that the patient receives the right information at the right time and in the 
right format. Furthermore, the CTNs take time to answer patients’ queries and acknowledge 
that if they are unable to answer or require further clarification, they will undertake to do so. 
CTNs are guided by their nursing knowledge and skills when facilitating information flow to 
the patient. The CTNs in this study constantly referred to the importance of listening to 
patients, giving patients up to date information, obtaining correct information for patients and 
ensuring that practices were guided by international good clinical practices. They also use 
their interpersonal skills as they manage and coordinate clinical trials, by establishing and 
maintaining contact with the ethics committee, other clinical trials centres, the study sponsor, 
other key stakeholders and most importantly the PI. These findings are also supported by 
literature (Poston and Buescher 2010; Bell 2009; Yin 2008; Cantini and Ells 2007; Rickard et 
al., 2006; Fisher 2006; Mueller 2001).  
These interpersonal skills are part of the ability of the CTN to communicate a caring attitude, 
and this attitude was commented on by both PIs and CTNs participating in this study. This 
was often articulated in terms of general attitude and manner, where the CTNs displayed 
attentive listening, providing information so the patient can make an informed decision, 
honesty, patience, responsibility, comforting, sensitivity and respect. The act of caring 
features quite prominently in nursing philosophy and practice and can be considered as 
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inherent and fundamental to nursing, as well as what differentiates nursing from other health 
related activities (Borbasi and Jackson, 2000).  
Caring in nursing has many definitions, including that of an invisible factor which is often not 
recognised except when it is seen in actions and attitudes (Jackson and Borbasi, 2000). Morse 
and colleagues (1991p. 3) identified five main views on the nature of caring, which are, 
‘caring as a human trait, caring as a moral imperative or ideal, caring as an emotion or affect, 
caring as an interpersonal relationship and caring as a therapeutic intervention’. Nevertheless, 
while care in nursing is multifaceted and complex it is about commitment to the wellbeing of 
the whole person. Watson’s theory (Watson, 2003) asserts that caring interaction is achieved 
by helping the patient gain a higher degree of harmony within the mind, body, and soul. This 
leads to a holistic perspective and allows for the provision of individualised nursing care 
(Jackson and Borbasi, 2000).  
Thus, many of the actions of the CTNs reported in this study can be understood and 
interpreted as nurse caring behaviours and as part of the nursing aspect of the CTN role. 
Nurse caring behaviours such as availability, gentleness, understanding and friendliness are 
reflected in the different roles that the CTNs assume in clinical trials. For example, in gaining 
consent, the CTN is open and spends time listening and answering patient queries honestly, 
which reflect a caring behaviour.  
Because patients are viewed as a whole person and their needs and concerns are addressed 
individually, this type of action on the part of the CTN leads to the development of a trusting 
relationship with the patient. In this research study, the CTNs indicated that it is of utmost 
importance that patients feel safe and comfortable with them, in order to develop a trusting 
and lasting professional relationship. Establishing relationships with patients is very much a 
central aspect of nursing practice as nursing practice involves managing, looking out for and 
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ensuring that the patient has the best possible care whilst under the nurse’s responsibility, 
regardless of the setting (Diers, 2004). CTNs are constantly monitoring patients, gathering 
data that are both clinically and research relevant and assessing patients both emotionally and 
physically to ensure that the patient is able to cope with participation in the clinical trial.  The 
rapport with patients resulting from these actions may have a positive impact on the retention 
of patients thus leading to a  more successful trial outcome (Fisher 2006; Mueller and Mamo 
2002). 
Personal characteristics are equally important in the expression of caring (McCance 2003). A 
few of the PIs in this study indicated that it requires someone with empathy and integrity to 
coordinate clinical trials and suggested that this is engendered in the nursing profession.  The 
CTNs in this study stated that their position in clinical trials does require someone with an 
understanding of the disease process and an understanding of the patients’ emotional and 
physical needs, to make the role a successful one. 
In summary, a holistic, caring approach fostered by CTNs not only results in successful 
management of clinical trials research but also humanises the research process for the 
patients. This section has highlighted how the CTNs draw upon their nursing knowledge and 
skills in their role in clinical trials research. The CTNs facilitate the promotion of patients’ 
wellbeing throughout the trial, using skills which are central to nursing practice through their 
knowledge of disease, their knowledge of the specific population under study and which 
include assessment, implementation and evaluation of care. 
5.2 Implications 
The findings of this study suggest that nurses working in clinical trials can no longer simply 
be perceived as research assistants who are mainly responsible for gathering clinical trial 
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data. With the increase in the number and complexity of clinical trials research in Australia, 
the CTN role has become more specialised. CTNs now hold central positions in coordinating 
and managing trials, as well as responsibility for trials-related patient care. As a role in 
transition, clinical trials nursing is still attempting to build a clear identity and position for 
itself within nursing and clinical research. This study has shown that nurses working in a 
clinical trials research position do not always have clear links with a nursing professional or 
organisational structure and thus do not have the opportunity to influence policy or develop 
leadership skills in this field.  
This study has found that there is currently a lack of career structure for CTNs. Review of 
current literature and interview data presented in this study confirms that the CTNs often felt 
ill prepared in relation to their research skills. In order to maximise capacity, nursing needs to 
develop models for clinical academic career pathways that define leadership roles and map 
training routes for novice researchers in clinical trials and other research roles. To establish a 
career pathway, relevant and appropriate research skills training and education has to be 
available and accessible to CTNs in order to support them to progress in a clinical trials 
research role at a nationally recognised educational institute.  
Clinical trials research investigators understand and appreciate the competence that nurses 
bring to clinical trials coordination. CTNs enter the clinical trials role from diverse clinical 
nursing backgrounds, as indicated by this research study. Although not all CTNs have the 
clinical specialty background directly related to the clinical trial, they do have a strong 
clinical training background and are therefore more able to make the transition into this role. 
CTNs are involved in educating participants in the clinical trials process and the disease 
interventions being studied, therefore it would appear that to achieve better outcomes for 
successful trial conduct, educational preparation beforehand should be more readily available. 
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These findings highlight the need for a tailored CTN orientation program to prepare for this 
role. The program should include current relevant clinical practice, up to date processes for 
ethics submission, guidelines and review, and certainly continuing training modules in the 
disease specialty that the CTN is involved in.  
A major recommendation from the McKeon Review (www.mckeonreview.org.au, February 
2013) was the implementation of a long-term strategic policy framework to guide and support 
clinical trials’ workforce in order to meet Australia's clinical research workforce needs.  Key 
elements summarised in this review include meeting demand for research skills in Australia 
and identifying the issues, actions and needs associated with increasing participation in 
Australia's research workforce.  
 
Greater harmonisation of the CTN position description to incorporate nursing specialist 
practice and research would certainly enhance the quality of the workforce entering into 
clinical research positions. Providing remuneration according to the level of expertise in 
clinical and research skill would also enable greater retention of the CTN workforce and 
employment on a more permanent rather than temporary contractual basis. This would enable 
a research facility to grow with staff that is dedicated and well trained thus achieving 
excellence in clinical trial coordination. Also greater involvement of nurses in protocol 
development and the publication and dissemination of results would contribute significantly 
to career enhancement as CTNs would be acknowledged for their participation as researchers 
and be recognised for their collegial and professional practice. 
5.3 Conclusion 
With the increasing numbers of clinical trials and greater complexity around their design and 
management, nurses are being challenged to perform a more diverse role in clinical trials 
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research. This study has highlighted the diverse role that CTNs play in the course of clinical 
trials research conduct and management.  During the course of conducting and managing 
clinical trials, CTNs draw upon their core nursing attributes, knowledge and skills as defined 
and described in this chapter.  
The subthemes found through the interview analysis: Functioning from a Professional and 
Ethical Nursing Perspective and Applying Therapeutic Knowledge and Clinical Skills 
individually but collectively explain how CTNs essentially practice as registered nurses. The 
CTNs and PIs interviewed for this study describe characteristics of the CTN that reflect 
practices based on a professional nursing framework such as caring, autonomy, moral 
competency, problem solving skills and decision making skills. The CTNs transfer their 
nursing skills seamlessly into the clinical trial research role which enables them to practice 
within a nursing domain thus ‘Being a Nurse‟. 
However, in practising within a professional nursing framework, the challenge of marrying 
both a researcher and a caregiver role has arisen. In order to progress, nurses working in 
clinical trials roles should work to define and describe their roles and make clear distinctions 
between themselves and other professional groups who function in clinical trial coordination 
and management roles. CTNs need to network with other CTNs, form professional groups 
and conduct further research into their role, as well as publish frameworks or specialist 
competencies for their roles in order to assist others in describing, recognising and 
understanding the role for themselves. 
Articulating the role of a CTN and recognising the dual roles and perspectives of being a 
nurse and a researcher are important and the first of many steps to come. This study is the 
first study to explore and acknowledge the dual role of CTNs (that is, nurse and clinical trials 
researcher) held by RNs in various clinical trial specialities. Recognising that the CTN role 
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requires further study enables leaders in nursing to focus and develop this unique role thus 
ensuring nurses can embrace clinical trial coordination roles with greater confidence and 
leadership. 
The next chapter will summarise the major findings and implications of this study and present 
limitations of the research. Limitations and recommendations of this research project are 
discussed in the wider context before concluding. 
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Chapter 6: Conclusion 
6.0 Introduction  
In this concluding chapter the major findings are summarised.  Limitations and 
recommendations of this research project in its wider context are also discussed. The primary 
aim of this study is to contribute to the understanding of the role of registered nurses working 
in clinical trials research who for this study have been labelled as clinical trials nurses (CTN). 
This is a qualitative, interpretive research study conducted to gain a deeper perception of 
what it is to be a CTN in the Australian context. Little is known of the role of CTNs and their 
relative contribution to clinical trials research in Australia. This research study is the first 
investigation of its kind to better understand the contributions made and challenges faced by 
CTNs in Australia.   
6.1 Summary of Findings 
This research study has examined the role of CTNs in conducting and managing clinical trials 
in two large metropolitan public hospitals in New South Wales, Australia. Semi structured 
interviews were conducted to gain CTNs’ and PIs’ perspective of the CTNs role. Data 
analysis was conducted according to principles of Gadamerian hermeneutics, and revealed 
two subthemes Functioning within a Professional and Ethical Nursing Framework and 
Applying Therapeutic Knowledge and Clinical Skills, contributing to an overall theme Being 
a Nurse. The themes provide illuminating insights into the experiences of nurses working in a 
different and challenging nursing role, from the perspective of both CTNs and PIs. Each of 
the themes that emerged from the data analysed in this study, provide a lens into the world of 
CTNs working in clinical trials research. The two subthemes provide a detailed 
understanding of the role of CTNs bring together, under the overarching theme Being a 
Nurse.  
115 
 
The analysis of the data revealed that the CTNs in this study essentially displayed distinct 
attributes of nursing in their role. This main finding is not unsurprising to comprehend 
because they are indeed nurses by profession, with a considerable background in general 
nursing and specialty clinical nursing, prior to embarking on a career in clinical trials 
research. The CTNs conveyed their nursing traditions, philosophy, knowledge and expertise 
as well as their personal traditions and attributes to the clinical trials nursing role. Therefore, 
CTNs as nurses are shaped by their prior experiences, to care for and manage patients using 
nursing framework, codes and practices.  
It was clear from the data that CTNs utilised their nursing skills and expertise to contribute to 
patient care and clinical research simultaneously. CTNs are responsible for fulfilling the 
requirements of the clinical trial protocol, clinical research standards and guidelines and to 
promote a research environment within a healthcare setting, as well as practice within a 
nursing framework. In essence, the CTNs in this study indicated that they adopted codes and 
standards of practice to the environment that they worked in, be it a clinical or clinical 
research setting. These research findings suggest that CTNs continue to utilise their nursing 
skills and expertise in their role, contributing to the care of trial participants in a variety of 
ways. Through playing a dual role of both caregiver and researcher, the analysis revealed that 
tensions arise between the enactment of these two roles, where CTNs in essence combine 
both a role in research alongside professional nursing roles and responsibilities. CTNs are 
negotiating a range of competing loyalties, due to the interplay between their professional 
nursing role and their role in clinical research. 
The analysis of the data indicates that the CTNs bring a variety of practical, organisational 
and interpersonal skills to their role in clinical trials research. However, the data also suggest 
that the CTNs’ main point of difference lies in their ethical approach to patient care and their 
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ability to incorporate nursing care into their clinical research role; how these factors 
contribute to the outcomes of clinical trials research and to the patients’ experience as 
participants in clinical trials research is not fully known which requires further research. 
The research study has identified that CTNs bring an in depth knowledge base, critical 
thinking, decision making skills and clinical practice that is underpinned by an ethical and 
professional nursing framework. Previous studies conducted in an Australian context 
(Roberts et al., 2011; Rickard et al., 2006) have only investigated a particular clinical 
specialty and not all participants were nurses. This study, however, has contributed to 
growing evidence concerning an approach to professional practice of CTNs in Australia by 
studying the perspectives of a diverse group of CTNs of different clinical specialties, 
obtaining the viewpoint of PIs who work with CTNs closely and using hermeneutics to gain a 
deep understanding of the CTN role.  
6.2 Strength and Limitations of this Study 
The main strengths of this study stem from the methodology used: qualitative research to 
investigate the role of registered nurses in clinical trial research. The investigative methods 
utilised in this research study are particularly suited to aims that require in depth exploration 
of human experiences and meanings.  
Semi structured interviews were used to gain an in depth insight into their role as clinical 
trials nurse. The use of semi structured interviews provided the researcher with data that was 
reliable and comparable. A major strength of this method of interviewing was that it allowed 
for a two way communication, therefore enabling a process of giving and receiving 
information. Furthermore, this method of interviewing provided the researcher flexibility to 
probe for details and discuss issues as they arose. Direct interactions with the study 
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participants developed and facilitated good relationship with them enabling rich data to be 
generated. Hermeneutic strategies allowed the researcher to draw upon her own professional 
insight, reflecting iteratively on the language of the participants and the theoretical 
underpinnings of the research. As previously stated in Chapter one, the researcher is a clinical 
trials nurse herself, therefore able to draw upon her own experiences when listening and 
reading interview transcripts. 
An additional strength of the study is that participants were drawn from two different 
professional groups that work in clinical trials research environment. One was the CTNs 
themselves and second medical practitioners who work closely with CTNs identified as PIs. 
No other research studies in Australia at present have included medical practitioners in their 
research study. The advantage of including PIs in the research study provided a broader and 
deeper understanding of the role that RN play in clinical trials research, mainly because CTN 
positions are currently reporting directly or indirectly to PIs as literature review and the 
findings of this research have established.  
 
Further strength of this research study is that the pool of participants was drawn from a 
variety of clinical specialties which intensifies the exploration of the role of CTNs. Most of 
the studies conducted in Australia and internationally as reflected in Table 2.4 (Appendix E) 
explored one group of clinical speciality such as Oncology rather than an array of clinical 
specialities. In exploring various clinical specialities that the CTNs work in, the present study 
offers an in depth understanding of the role that RNs play in clinical trial research. 
Consequently, the present study findings are transferable to outside this study setting. 
 
A limitation of the study is that two of the participants were known to the researcher as they 
had worked together previously in similar roles. However, the insights provided by the 
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researcher gained directly from her knowledge of what some of the participants had 
undertaken in their clinical trials role, may alternatively be seen as a way of enhancing and 
enriching the quality of the data. As a CTN herself, the interpretation of the data is framed 
from her own professional background and hence what is viewed of the data will be different 
to that of a non-CTN or someone who has no experience in this context.  
The researcher acknowledges and recognises that her own experiences are considered an 
asset to the type of methodology used in this research study, as her experiences provide an 
important contribution that assists with the interpretation of the data. In addition, the use of 
direct quotes taken from the transcripts to support the interpretation helps to assure the rigour 
of the findings and assist the reader to connect the voice of the participants with the 
researcher’s interpretation. 
 
One other limitation was what one can achieve in the given time frame. In this study, 
challenges related that of a protracted ethics submission and approval processes were 
encountered. The ethics submission for this research study took longer than anticipated due to 
the length of time and number of ethics applications that had to processed and submitted. The 
study was conducted in hospitals belonging to one area health which is Sydney and South 
West Area Health Service. The study had to first gain approval through the University of 
Sydney Ethics Committee before even applying to the appropriate Area Health Service ethics 
committees. Once University of Sydney HREC approved the study, application was made to 
the Area Health Service HREC. However, the researcher was then informed that 
simultaneous applications to the hospitals within the same Area Health Service were not 
permitted. This process took six to eight months to complete which impacted upon the 
timeframe for the conduct of the research study and specifically data collection. The ethics 
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process has since changed in New South Wales to allow for single submissions to multi-
centre sites. 
Whilst the findings of the research are immediately applicable in the world of CTNs in 
Australia, it must be acknowledged that this relates to specific research settings. It is not clear 
if the findings can be generalised to other research settings and countries where work 
environments are different. Nevertheless the study raises questions and points to a need for 
further research in broader settings. 
6.3 Further Research Recommendations 
Further research is required in order to deepen the understanding of the evolving role of 
CTNs. The study has identified several major challenges in current CTN practice and clearly 
further research is required in this evolving role of CTNs. Such research could prove to be 
useful to nurse educators and leaders interested in the advancement of nursing’s professional 
status in the division of health care labour as well as those nurse educators and leaders 
interested in advancing the role and practice domain of nursing in clinical trials research. 
Two lines of research should be conducted. First, comparative studies of the roles and work 
related tasks and skills of nurses and non-nurse trial coordinators should be undertaken. Such 
studies would be useful in delineating the role of CTNs in clinical trials research and in 
developing educational programs for both nurses and non-nurse careers in the domain of 
clinical research. Second, explorations of ethical conflicts and resolutions should be 
undertaken specific to the role that CTNs play in clinical trials research as it would make 
important contributions to policy development of ethics and practice of human centred 
biomedical research. 
Another area of future research is the assessment of CTNs’ influence over the recruitment of 
patients into clinical trials research. Participants in this study and anecdotal literature have 
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alluded that CTNs (Scott et al 2011, Bell 2009, Yin 2008, Stephens Lloyds 2004, Waller 
2003, Davis et al 2002) have a unique role in the process of recruiting patients to active 
clinical trials. Further research to validate this impression is required, because, ultimately, a 
greater understanding of the relative role of CTN factors will be important in the 
development of ethical and supportive strategies to optimise the recruitment of patient into 
clinical trials research. 
6.4 Recommendations for Practice 
The findings of this research study emphasises the need to establish a clear definition and 
description of the CTN role as an essential starting point for developing the role further. 
Without greater clarity, it is difficult to develop appropriate career pathways, improve 
opportunities for relevant educational and professional development and greater recognition 
for the role. Absence of career structure is identified as a major professional issue by the 
CTNs in this research study. 
Recommendation 1 
The increasing national investment in research, strategic emphasis on research governance 
and requirement to demonstrate quality patient care means it has never been more important 
that nurses with research expertise inform organisational and local research policy. The study 
has shown that CTNs do not always have clear links with nursing structures and thus do not 
have the opportunity to influence policy or develop leadership skills. 
Multi agencies including policy makers, clinical research industry and ANMC should 
facilitate CTNs to develop a leadership role and encourage input at a strategic and 
operational level. 
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Recommendation 2 
Within the CTN cohort there is a variety of job titles, grades and levels of responsibility. This 
situation creates uncertainty around accountability and responsibility both for staff to assume, 
for the organisation to expect and for the organisation to adopt for this nursing cohort. For 
professional indemnity it is important that clear lines of responsibility are outlined. 
There should be a single approach to recruitment of CTNs including harmonisation of job 
titles, job descriptions to clarify roles and responsibilities and remuneration standardisation 
across Australia. 
Recommendation 3 
Research governance requires all members of the research team be qualified by education, 
training and experience to perform their tasks. This study has shown wide variation in job 
descriptions, assumed levels of responsibility and preparation for the role in terms of 
education and training. 
There should be consensus around a set competency standards for all CTNs. 
Recommendation 4 
Relevant and appropriate research skills training and education has to be available and 
accessible to CTNs in order to support the achievement of competent research activity and 
high quality clinical practice.  
There needs to be provision of training and education for research skills to enable the 
achievement of competency in conducting, designing and leading research.  
Recommendation 5 
The majority of CTNs are involved in the central elements of the research process: participant 
identification, recruitment, delivery of interventions, assessments and procedures and data 
collection. To a lesser extent they are also involved in the polar ends of the clinical research 
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process including, protocol development, trial reporting and dissemination. Few CTNs are 
involved in the publication of the research they are involved in.  
CTNs should be encouraged and supported by the organisations that they work in to be 
active proponents in all stages of the research process, from protocol development to 
publication and dissemination of results. 
6.5 Conclusion 
The role of the CTN is diverse, dynamic and integral to the clinical trials process. It is still a 
role in transition; therefore no agreed definitions exist to the job title or description. This 
research study has identified that CTNs distinctly convey nursing traditions and philosophy in 
their role in clinical trials research. The CTNs in this study described and discussed their 
professional nursing role which included consent process as underpinned by ethical and 
professional nursing. The research study also revealed that CTNs use nurse orientated input 
into clinical trials research such as in depth knowledge base, critical thinking, clinical skills 
and decision and problem solving skills. The research study revealed that CTNs appear to 
hold a dual role as both researcher and caregiver. 
 
CTNs practising in the clinical trials research need to define and clarify their role. The 
development of a career structure is hindered by the proliferation of titles currently used by 
CTNs. There needs to be a clear career structure and pathway which would allow CTNs to 
develop their practise and make clear distinctions between them and other professional 
groups who function as coordinators, but not as nurses. It is imperative that the nursing 
profession determines the appropriate career pathway for nurses pursuing a career in clinical 
trials research; otherwise they may find others doing it for them. 
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Appendices 
Appendix A: Interview questions for Clinical Trials Nurses: 
GUIDELINE ONLY 
1. How did you become a clinical trial nurse? 
-Describe experience in clinical nurse 
-Why this role? 
2. Tell me about your role and responsibilities as a clinical trials nurse. 
3. Do you play any part in the process of gaining informed consent for clinical trials? 
4. Please describe how this role differs from that of the medical practitioner obtaining 
informed consent? 
5. Tell me about the information that you routinely give to patients about clinical trials 
and the issues that you may or may not discuss with patients. 
6. Do you find that patients ask you questions that you feel are better addressed by their 
physicians during the consent process? 
7. In your professional opinion, who should questions about clinical trials be directed to? 
8. Could you describe any concerns you might have about the way in which informed 
consent is obtained by medical practitioners? 
9. Would you be confident in gaining informed consent yourself if permitted? 
10. Do you see yourself as a patient advocate? 
11. If you were offered training in this area, what aspects would you like covered? 
12. Who do you think is the best person to fulfill your current role?  
13. Do you see the role of clinical trials nurse changing in the future? 
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Interview questions for Medical Practitioners involved in Clinical Trials: 
1. How do you perceive the role of clinical trials nurses? 
2. Please describe what is your role in the process of gaining informed consent to 
clinical trials? 
3. Would you feel confident and comfortable with clinical trial nurses gaining consent to 
clinical trials? Please elaborate. 
4. Please describe your working relationship with clinical trials nurses. 
5. What qualifications do you see clinical trials nurses equipped with? 
6. Do you see clinical trials nurses as patient advocates?  
7. Do you think that clinical trials nurses are an important asset to the success of clinical 
trials? 
8. In your professional opinion, do you see clinical trial nurses as an important asset to 
the success of a clinical trial? 
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Appendix B1: Participant Informed Consent for Clinical Trials Nurses 
 
CLINICAL TRIALS NURSES AND THE INFORMED CONSENT PROCESS 
PARTICIPANT INFORMATION STATEMENT FOR CLINICAL TRIALS NURSES 
 
You are invited to take part in a research study Clinical trials nurses and the informed 
consent process: exploration of the role. The object of this study is to define the role of 
clinical trials nurses and to explore their part in gaining consent in clinical trials. The study is 
being conducted by Thili Chengodu and will form the basis for the degree of MPh at the 
Faculty of Nursing and Midwifery, University of Sydney under the supervision of Professor 
Kate White, Dr Susan Jones and Professor John Thompson 
 
 
If you agree to participate in this study, you will be asked to participate in an interview with 
the researcher. This interview will explore your experiences as a clinical trials nurse, your 
working relationship with other health professionals within your team and the process of 
gaining consent for trial participation from eligible patients. The interview will take 30 to 45 
minutes and, with your permission, the interview will be recorded on tape and will be 
transcribed and analysed soon after completion of the interview. You will be given a 
pseudonym to protect your identity and only the researchers will have access to the tapes 
which will be stored in a locked facility in the Faculty of Nursing and Midwifery, University 
of Sydney. You will be invited to attend the Faculty of Nursing and Midwifery for the 
interview or may choose somewhere more convenient to you, at a time suitable for you.  
 
All aspects of the study, including the findings, will be strictly confidential and only the 
investigators named above will have access to information on participants. Papers from the 
study will be submitted for publication but individual participants will not be identifiable. 
Participation in this study will not bring direct benefit to you. However, by assisting in the 
research study, you will be part of the wider nursing community that constantly endeavours 
to define its role and responsibilities in terms of nursing practice. You are welcome to discuss 
this research study with anyone you choose. It will not affect the outcome of the study. 
 
Participation in this study is entirely voluntary. You are not obliged to participate and, if you 
do participate, you can withdraw at any time. Whatever your decision, it will not affect your 
relationship with the researchers or the University of Sydney. 
 
When you have read this information, Thili Chengodu will be pleased to discuss it with you 
further and answer any questions you may have. If you would like to know more at any stage, 
please feel free to contact Professor Kate White on 9351 0778 or Thili Chengodu on 0415 
536 003 or 9351 0581. This information sheet is for you to keep and thank you for your time 
in reading it. We hope that you will be interested in participating in this study. 
 
 
Any person with concerns or complaints about the conduct of a research study can 
contact the Manager for Ethics Administration, University of Sydney on (02) 9351 4811. 
 
 
 
133 
 
Appendix B2: Participant Informed consent for Medical Practitioners 
 
CLINICAL TRIALS NURSES AND THE INFORMED CONSENT PROCESS 
PARTICIPANT INFORMATION STATEMENT FOR MEDICAL PRACTITIONERS 
INVOLVED IN CLINICAL TRIALS 
 
You are invited to take part in a research study Clinical trials nurses and the informed 
consent process: exploration of the role. The object of this study is to define the role of 
clinical trials nurses and to explore their part in gaining consent in clinical trials. The study is 
being conducted by Thili Chengodu and will form the basis for the degree of MPh in the 
Faculty of Nursing and Midwifery, University of Sydney under the supervision of Professor 
Kate White, Dr Susan Jones and Professor John Thompson 
 
If you agree to participate in this study, you will be asked to participate in an interview with 
the researcher. You will be asked about your views on the role of clinical trials nurses, your 
working relationship with them and the process of gaining consent for trial participation from 
eligible patients. The interview will take 20 to 30 minutes and, with your permission, the 
interview will be recorded on tape and will be transcribed and analysed soon after completion 
of the interview. You will be given a pseudonym to protect your identity and only the 
researchers will have access to the tapes which will be stored in a locked facility in the 
Faculty of Nursing and Midwifery, University of Sydney. You will be invited to attend the 
Faculty of Nursing and Midwifery for the interview or may choose somewhere more 
convenient to you, at a time suitable for you. 
 
All aspects of the study, including the findings, will be strictly confidential and only the 
investigators named above will have access to information on participants. Papers from the 
study will be submitted for publication but individual participants will not be identifiable. 
Participation in this study will not bring direct benefit to you. However, it will assist the 
researchers to better understand the role of clinical trials nurses and the working relationship 
that principal investigators have with clinical trials nurses. This information may, in future, 
be of assistance to both nurses and principal investigators in their various roles within the 
clinical trials team. You are welcome to discuss this study with anyone you choose. It will not 
affect the outcome of the study. 
 
Participation in this study is entirely voluntary. You are not obliged to participate, and if you 
do participate, you can withdraw at any time. Whatever your decision, it will not affect your 
relationship with the researchers or the University of Sydney. When you have read this 
information, Thili Chengodu will be pleased to discuss it with you further and answer any 
questions you may have. If you would like to know more at any stage, please feel free to 
contact Professor Kate White on 9351 0575 or Thili Chengodu on 0415 536 003 or 9351 
0581. This information sheet is for you to keep and thank you for your time in reading it. We 
hope that you will be interested in participating in this study. 
 
This study has been approved by the Ethics Review Committee (RPAH Zone) of the 
Sydney South West Area Health Service. Any person with concerns or complaints about 
the conduct of this study should contact the Secretary on (02) 9515 6766 and quote 
protocol number X05-0087 
 
Any person with concerns or complaints about the conduct of a research study can 
contact the Manager for Ethics Administration, University of Sydney on (02) 9351 4811. 
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Appendix C: Consent Form 
 
CONSENT FORM 
 
I, ............................................................... , give consent to my participation in the research 
project: 
 Name (please print) 
 
Clinical trials nurses and the informed consent process 
 
In giving my consent I acknowledge that: 
 
 
1. The interview required for the project have been explained to me, and any questions I 
have about the project have been answered to my satisfaction. 
 
2. I have read the Participant Information Statement and have been given the opportunity 
to discuss the information and my involvement in the project with the researcher/s. 
 
3. I understand that I can withdraw from the study at any time, without affecting my 
relationships with the researcher(s) and the University of Sydney now or in the future. 
 
4. I understand that my involvement is strictly confidential and no information about me 
will be used in any way that reveals my identity. 
 
 
 
 
Signed: .................................................... Date: .................................... 
 
 
Name:  ..................................................……………………………………… 
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Appendix D: Advertisement 
 
 
CALLING ALL 
RESEARCH NURSES 
 
 
ARE YOU CURRENTLY WORKING IN 
TRIALS? 
 
HAVE YOU WORKED IN TRIALS 
BEFORE? 
 
WOULD YOU LIKE TO SHARE YOUR 
EXPERIENCES WORKING IN A TRIAL? 
 
If you are, we would like to invite you to join a study investigating 
the role of clinical trials nurse. 
 
CALL THILI CHENGODU ON  
93510562 or 0415 536 006 
 
This study has been approved by the University of Sydney 
Human Research Ethics Committee 
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Appendix E: Table 2.4: Summary of Empirical Studies on Role of Registered Nurses Working in Clinical Trial Coordination Roles 
 
Author Year Country Method Description Sample Conclusion 
Wilkes et al 2012 Australia Quantitative-
questionnaire 
To determine the 
scope and 
contribution of 
the role that 
clinical trial 
nurses play in 
clinical trials in 
Australia and also 
to explore 
professional 
issues 
N=67 The results of the survey highlights the 
complexities of the professional role of the CTNs. 
Scott et al 2011 Australia Questionnaire 
and Focus 
Group 
To evaluate the 
knowledge and 
skills of cancer 
clinical trials 
nurses in 
Australia and to 
gain a better 
understanding of 
their educational 
and training 
needs. 
N=61 A national survey data is reported to be reliable and 
valid. The data has also contributed to better 
understanding the knowledge and skills of cancer 
clinical trials nurses in Australia and development 
of postgraduate course in clinical trials at the 
University of Sydney 
Nagel et al 2010 USA Quantitative-
questionnaire 
To describe the 
roles and 
responsibilities of 
the CRN in 
paediatric 
oncology. 
N=85 Clinical specialisation of RNs has increased 
significantly and nurses are responsible for 
performing different roles that contribute to the 
success of CT 
Habermann et al 2010 USA Quantitative- To describe N=266 The study demonstrates the need to expand 
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Author Year Country Method Description Sample Conclusion 
questionnaire research 
coordinators' 
experiences with 
scientific 
misconduct in 
their clinical 
environment. 
definitions of scientific misconduct beyond 
fabrication, falsification, and plagiarism to include 
other practices. The importance of the ethical 
climate in the institution in ensuring a safe 
environment to report and an environment where 
evidence is reviewed cannot be overlooked. 
 
 
Catania et al 2008 Italy Quantitative-
questionnaire 
An assessment of 
the research nurse 
role in Italy 
N=30 The new validated survey instrument will be used 
in a national survey aimed at assessing the role of 
the Italian clinical trials research nurse and support 
to delineate the framework of the general 
competencies required for basic and advanced 
levels of practice for nurses involved in clinical 
trials research 
Jeong et al 2007 S Korea Quantitative-
questionnaire 
To determine the 
roles, proficiency 
and qualification 
of CRN in South 
Korea 
N=150 
PI=71 
CRN=
79 
Communication and human relationship are the 
most important skills for CRNs with minimum 
Bachelors degree and one year experience in CT. 
Cantini and Ells 2007 Canada Quantitative-
questionnaire 
To elicit 
information about 
the practice CTN 
in the informed 
consent process 
N=95 Results of the study point to the need for standard 
ethical and practical guidelines with respect to the 
role of the CTN in the informed consent process 
Spilsbury et al 2007 UK Qualitative -
focus group 
To explore the 
scope and 
potential 
contribution of 
the CRN role to 
clinical trials 
research of 
nursing specific 
topic 
N=9 The study reveals challenges associated with 
training and management of CRNs and 
contributions to nursing specific trials. 
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Author Year Country Method Description Sample Conclusion 
Gwede et al 2005 USA Quantitative-
questionnaire 
To assess burnout 
among CRC and 
to determine 
which personal 
and job related 
factors are 
associated with 
burnouts 
N= 
252 
Burnout is prevalent in CRC 
Fisher 2006 USA Qualitative-
interviews 
Examination of 
the role RC in the 
conduct of 
contract research 
in USA 
N=57 Study demonstrates how clinical trial coordinators' 
focus on ethics is a response to their role conflict 
and an attempt to reinsert individualised care in to 
the context of research. 
 
Easter et al 2006 USA Qualitative-
interviews 
To investigate 
how the 
researchers and 
subjects who 
participate in CT 
understand the 
presence of care 
in research 
N=82 
 
CRN=
18 
Patient 
=45 
PI=19 
Researchers and subjects perceived many kinds of 
care in researcher roles and relationships and often 
these relationships were both 'different and better' 
Rickard et al 2006 Ausrtralia 
and New 
Zealand 
Quantitative - 
questionnaire 
To ascertain 
demographics, 
education, 
employment 
history, job 
structure and role 
content 
N= 49 The study indicated that most research coordinators 
were highly qualified and experienced nurses who 
undertake pharmaceutical trials, multi centre trials, 
medical and nursing researchers, audits, data 
management and their own research. 
Hill and 
MacArthur 
2006 UK     
Study 1 2002  Qualitative-
questionnaire 
To identify and 
elicit information 
N=72 Research nurses need to be supported through 
educational means, their contractual agreement 
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Author Year Country Method Description Sample Conclusion 
in regards to 
human resources 
issues 
clarified, better supported and supported in 
developing nurse led research. 
Study 2 2003  Questionnaire 
and focus 
group 
To explore 
experiences and 
knowledge 
specifically 
professional 
development and 
support issues 
N=50  
Simpson 2006 UK Quantitative-
questionnaire 
To identify the 
research roles 
provided by 
nurses and 
midwives and to 
understand their 
professional 
development 
needs 
N=116  
Deave 2005 UK Qualitative -
documentary 
analysis 
To identify 
whether 
knowledge of 
research is stated 
in employment 
advertisements 
N=82 
in 
2002 
N=75 
in 
2005 
Knowledge or experience of research not usually a 
requirement for the research nurse post 
Rico-
Villadermoros et 
al 
2004 Spain Qualitative-
questionnaire 
Determine 
standard tasks 
performed by 
CRC in oncology 
clinical trials 
research 
N=41 CRC play a key role in the implementation of 
oncology clinical trials research which goes far 
beyond data collection and administrative duties 
and directly contributes to the gathering of quality 
data. 
Ehrenberger and 
Lilington 
2004 USA and 
Canada 
Questionnaire 
and focus 
group 
To identify the 
significant 
dimension of the 
N=40 The CTNQ has acceptable content validity, internal 
consistency, and stability reliability and is a 
promising tool for the assessment of research nurse 
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Author Year Country Method Description Sample Conclusion 
role of CRN and 
to construct a 
reliable and valid 
survey instrument 
to reflect these 
dimensions 
role. 
Davis et al 2002 USA Qualitative-
Focus group 
To ascertain the 
role of study 
coordinators 
N=45 The study finds that study coordinators face 
challenging issues related to trial participants and 
require research ethical training 
Loh et al 2002 Australia Qualitative-
Focus group 
To explore the 
role of the data 
manager  and to 
determine the 
similarities and 
challenges of their 
role with that of 
the physicians in 
obtaining consent 
N=21 
Mix  
Health 
Prof 
Issues raised by data managers have important 
implications for successful conduct of clinical trials 
research, particularly the need for an integrated, 
multidisciplinary approach at all levels of the 
informed consent process. 
Grunfeld et al 2002 Canada Qualitative-
Focus group 
To identify 
barriers and 
facilitators to the 
accrual of patients 
with cancer 
regarding clinical 
trial entry, 
specifically from 
the CRA 
perspective 
N=29 Further research into the role of CRA impacting on 
the accrual of patients needed 
Mueller 2001 USA Qualitative-
Interviews 
To investigate the 
role, career and 
work experiences 
of nurse trial 
coordinators 
N=38 Nurse trial coordinators view their position as part 
medicine and part nursing. Nursing needs to show 
empirically if the role is exclusive to nursing 
Xanthos et al 1998 USA Qualitative- To delineate the N=23 Role of nurses in clinical trial identified, needs 
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Author Year Country Method Description Sample Conclusion 
questionnaire nurses' role in 
clinical trials 
research in terms 
of their job 
description 
educational and organisational support in future 
Aarigo et al 1994 15 
European 
Countries 
Qualitative-
questionnaire 
To identify nurses 
involved in 
clinical trials 
research and 
document their 
specific needs 
N=312 Nurses involved in clinical trials research need to 
be involved in clinical trial protocol development, 
networking with other nurses working on the trials 
and participate in clinical trial meetings. 
Ahern et al 1993 USA Quantitative-
questionnaire 
To document the 
different activities 
for which the trial 
coordinator 
assumed 
responsibility 
N=21 Study identified the need to develop a means to 
define characteristics, background and training 
appropriate for candidates in this position 
 
